{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T02:24:23Z","timestamp":1791944663197,"version":"4.3.4"},"reference-count":392,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T00:00:00Z","timestamp":1774828800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T00:00:00Z","timestamp":1774828800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK129885"],"award-info":[{"award-number":["R01DK129885"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK125459"],"award-info":[{"award-number":["R01DK125459"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL145528"],"award-info":[{"award-number":["R01HL145528"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pflugers Arch - Eur J Physiol"],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The kidney is a major regulator of phosphate metabolism. The body can lower systemic phosphate levels by increasing renal phosphate excretion, and kidney injury results in elevated serum phosphate concentrations (hyperphosphatemia). Chronic kidney disease (CKD) is associated with various organ injuries, including vascular calcification and cardiovascular disease, where hyperphosphatemia acts as a pathologic driver. Here we discuss hyperphosphatemia not as a consequence of kidney disease but as a potential contributor to kidney damage. We describe how increases in renal tubular phosphate levels (hyperphosphaturia), rather than hyperphosphatemia contribute to kidney injury in CKD. Tubular phosphate can form microcrystals with calcium which damages renal epithelial cells, induces fibrosis and inflammation, and causes parenchymal calcification. Calcium phosphate microcrystals can grow and form larger deposits in the renal collecting system, and potentially contribute to the formation of kidney stones. Therefore, hyperphosphaturia might not only contribute to kidney damage in CKD, but could also cause kidney injury in genetic diseases with reduced renal phosphate uptake. Finally, since high dietary phosphate intake increases renal phosphate excretion, we discuss if prolonged phosphate loading in the absence of CKD can induce kidney damage. We propose that a better understanding of the pathologic actions of phosphate on the kidney will help to identify novel therapeutic strategies to prevent renal injury and disease progression in patients with CKD and in other renal conditions, such as kidney stone formation. Lowering dietary phosphate intake might not only have reno-protective effects in patients with pre-existing kidney damage but also in healthy individuals.<\/jats:p>","DOI":"10.1007\/s00424-026-03160-5","type":"journal-article","created":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T00:33:55Z","timestamp":1774830835000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The effects of elevated phosphate on the kidney - damaging the gatekeeper"],"prefix":"10.1007","volume":"478","author":[{"given":"Tanecia","family":"Mitchell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abul","family":"Fajol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7512-0977","authenticated-orcid":false,"given":"Christian","family":"Faul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,30]]},"reference":[{"issue":"3","key":"3160_CR1","doi-asserted-by":"publisher","first-page":"F643","DOI":"10.1152\/ajprenal.00228.2007","volume":"293","author":"LV Virkki","year":"2007","unstructured":"Virkki LV, Biber J, Murer H, Forster IC (2007) Phosphate transporters: a tale of two solute carrier families. Am J Physiol Ren Physiol 293(3):F643\u2013F654. https:\/\/doi.org\/10.1152\/ajprenal.00228.2007","journal-title":"Am J Physiol Ren Physiol"},{"issue":"3","key":"3160_CR2","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1042\/CS20100377","volume":"120","author":"MS Razzaque","year":"2011","unstructured":"Razzaque MS (2011) Phosphate toxicity: new insights into an old problem. Clin Sci (Lond) 120(3):91\u201397. https:\/\/doi.org\/10.1042\/CS20100377","journal-title":"Clin Sci (Lond)"},{"issue":"4","key":"3160_CR3","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1097\/MNH.0000000000001090","volume":"34","author":"CA Wagner","year":"2025","unstructured":"Wagner CA, Egli-Spichtig D, Rubio-Aliaga I (2025) Updates on renal phosphate transport. Curr Opin Nephrol Hypertens 34(4):269\u2013275. https:\/\/doi.org\/10.1097\/MNH.0000000000001090","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"11","key":"3160_CR4","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/s41574-018-0076-3","volume":"14","author":"S Chande","year":"2018","unstructured":"Chande S, Bergwitz C (2018) Role of phosphate sensing in bone and mineral metabolism. Nat Rev Endocrinol 14(11):637\u2013655. https:\/\/doi.org\/10.1038\/s41574-018-0076-3","journal-title":"Nat Rev Endocrinol"},{"issue":"4","key":"3160_CR5","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.kint.2016.03.039","volume":"90","author":"H Komaba","year":"2016","unstructured":"Komaba H, Fukagawa M (2016) Phosphate-a poison for humans? Kidney Int 90(4):753\u2013763. https:\/\/doi.org\/10.1016\/j.kint.2016.03.039","journal-title":"Kidney Int"},{"issue":"1","key":"3160_CR6","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/nrneph.2016.164","volume":"13","author":"MG Vervloet","year":"2017","unstructured":"Vervloet MG et al (2017) The role of phosphate in kidney disease. Nat Rev Nephrol 13(1):27\u201338. https:\/\/doi.org\/10.1038\/nrneph.2016.164","journal-title":"Nat Rev Nephrol"},{"issue":"2","key":"3160_CR7","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/ki.2008.130","volume":"74","author":"KA Hruska","year":"2008","unstructured":"Hruska KA, Mathew S, Lund R, Qiu P, Pratt R (2008) Hyperphosphatemia of chronic kidney disease. Kidney Int 74(2):148\u2013157. https:\/\/doi.org\/10.1038\/ki.2008.130","journal-title":"Kidney Int"},{"issue":"8","key":"3160_CR8","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/s41581-019-0159-y","volume":"15","author":"M Levi","year":"2019","unstructured":"Levi M et al (2019) Mechanisms of phosphate transport. Nat Rev Nephrol 15(8):482\u2013500. https:\/\/doi.org\/10.1038\/s41581-019-0159-y","journal-title":"Nat Rev Nephrol"},{"issue":"2","key":"3160_CR9","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1093\/ndt\/gfad188","volume":"39","author":"CA Wagner","year":"2024","unstructured":"Wagner CA (2024) The basics of phosphate metabolism. Nephrol Dial Transpl 39(2):190\u2013201. https:\/\/doi.org\/10.1093\/ndt\/gfad188","journal-title":"Nephrol Dial Transpl"},{"issue":"12","key":"3160_CR10","doi-asserted-by":"publisher","first-page":"5358","DOI":"10.1210\/en.2005-0777","volume":"146","author":"F Perwad","year":"2005","unstructured":"Perwad F, Azam N, Zhang MY, Yamashita T, Tenenhouse HS, Portale AA (2005) Dietary and serum phosphorus regulate fibroblast growth factor 23 expression and 1,25-dihydroxyvitamin D metabolism in mice. Endocrinology 146(12):5358\u20135364. https:\/\/doi.org\/10.1210\/en.2005-0777","journal-title":"Endocrinology"},{"issue":"4","key":"3160_CR11","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1074\/jbc.M408903200","volume":"280","author":"H Saito","year":"2005","unstructured":"Saito H et al (2005) Circulating FGF-23 is regulated by 1alpha,25-dihydroxyvitamin D3 and phosphorus in vivo. J Biol Chem 280(4):2543\u20132549. https:\/\/doi.org\/10.1074\/jbc.M408903200","journal-title":"J Biol Chem"},{"key":"3160_CR12","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1172\/JCI131190","volume":"130","author":"P Simic","year":"2020","unstructured":"Simic P et al (2020) Glycerol-3-phosphate is an FGF23 regulator derived from the injured kidney. J Clin Invest 130:1513\u20131526. https:\/\/doi.org\/10.1172\/JCI131190","journal-title":"J Clin Invest"},{"key":"3160_CR13","doi-asserted-by":"publisher","unstructured":"Zhou W et al (2023) Kidney glycolysis serves as a mammalian phosphate sensor that maintains phosphate homeostasis. J Clin Invest 133(8). https:\/\/doi.org\/10.1172\/JCI164610","DOI":"10.1172\/JCI164610"},{"key":"3160_CR14","doi-asserted-by":"publisher","unstructured":"Fuchs MA, Wolf M (2023) Renal proximal tubule cells: power and finesse. J Clin Invest 133(9). https:\/\/doi.org\/10.1172\/JCI169607","DOI":"10.1172\/JCI169607"},{"issue":"1","key":"3160_CR15","doi-asserted-by":"publisher","first-page":"5794","DOI":"10.1038\/s41598-023-32856-2","volume":"13","author":"S Yasuda","year":"2023","unstructured":"Yasuda S et al (2023) Hepatic phosphate uptake and subsequent nerve-mediated phosphaturia are crucial for phosphate homeostasis following portal vein passage of phosphate in rats. Sci Rep 13(1):5794. https:\/\/doi.org\/10.1038\/s41598-023-32856-2","journal-title":"Sci Rep"},{"key":"3160_CR16","doi-asserted-by":"publisher","unstructured":"Fajol A, Faul C (2025) Soft tissue calcifications in chronic kidney disease-beyond the vasculature. Pflugers Arch Jun 5. https:\/\/doi.org\/10.1007\/s00424-025-03098-0","DOI":"10.1007\/s00424-025-03098-0"},{"issue":"3","key":"3160_CR17","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1161\/ATVBAHA.123.319198","volume":"44","author":"ME Turner","year":"2024","unstructured":"Turner ME et al (2024) Phosphate in Cardiovascular Disease: From New Insights Into Molecular Mechanisms to Clinical Implications. Arterioscler Thromb Vasc Biol 44(3):584\u2013602. https:\/\/doi.org\/10.1161\/ATVBAHA.123.319198","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"3160_CR18","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/ki.2015.76","volume":"88","author":"L Shavit","year":"2015","unstructured":"Shavit L, Jaeger P, Unwin RJ (2015) What is nephrocalcinosis? Kidney Int 88(1):35\u201343. https:\/\/doi.org\/10.1038\/ki.2015.76","journal-title":"Kidney Int"},{"key":"3160_CR19","unstructured":"Vaidya SR, Yarrarapu SNS, Aeddula NR (2025) Nephrocalcinosis. StatPearls. Treasure Island (FL). https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK537205\/"},{"key":"3160_CR20","doi-asserted-by":"publisher","first-page":"16008","DOI":"10.1038\/nrdp.2016.8","volume":"2","author":"SR Khan","year":"2016","unstructured":"Khan SR et al (2016) Kidney stones. Nat Rev Dis Primers 2:16008. https:\/\/doi.org\/10.1038\/nrdp.2016.8","journal-title":"Nat Rev Dis Primers"},{"key":"3160_CR21","doi-asserted-by":"publisher","unstructured":"Gerber JS et al (2024) Controlled dietary phosphate loading in healthy young men elevates plasma phosphate and FGF23 levels. Pflugers Arch Nov 27. https:\/\/doi.org\/10.1007\/s00424-024-03046-4","DOI":"10.1007\/s00424-024-03046-4"},{"issue":"4","key":"3160_CR22","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1172\/JCI109014","volume":"61","author":"N Bank","year":"1978","unstructured":"Bank N, Su WS, Aynedjian HS (1978) A micropuncture study of renal phosphate transport in rats with chronic renal failure and secondary hyperparathyroidism. J Clin Invest 61(4):884\u2013894. https:\/\/doi.org\/10.1172\/JCI109014","journal-title":"J Clin Invest"},{"issue":"12","key":"3160_CR23","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1038\/ki.2011.47","volume":"79","author":"T Isakova","year":"2011","unstructured":"Isakova T et al (2011) Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease. Kidney Int 79(12):1370\u20131378. https:\/\/doi.org\/10.1038\/ki.2011.47","journal-title":"Kidney Int"},{"issue":"4","key":"3160_CR24","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1093\/ndt\/gfl718","volume":"22","author":"L Craver","year":"2007","unstructured":"Craver L et al (2007) Mineral metabolism parameters throughout chronic kidney disease stages 1\u20135\u2013achievement of K\/DOQI target ranges. Nephrol Dial Transpl 22(4):1171\u20131176. https:\/\/doi.org\/10.1093\/ndt\/gfl718","journal-title":"Nephrol Dial Transpl"},{"issue":"4","key":"3160_CR25","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1053\/ajkd.1998.v31.pm9531176","volume":"31","author":"GA Block","year":"1998","unstructured":"Block GA, Hulbert-Shearon TE, Levin NW, Port FK (1998) Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis 31(4):607\u2013617. https:\/\/doi.org\/10.1053\/ajkd.1998.v31.pm9531176","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"3160_CR26","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1001\/jama.2011.308","volume":"305","author":"SC Palmer","year":"2011","unstructured":"Palmer SC et al (2011) Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis. JAMA 305(11):1119\u20131127. https:\/\/doi.org\/10.1001\/jama.2011.308","journal-title":"JAMA"},{"issue":"2","key":"3160_CR27","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1681\/ASN.2004070602","volume":"16","author":"B Kestenbaum","year":"2005","unstructured":"Kestenbaum B et al (2005) Serum phosphate levels and mortality risk among people with chronic kidney disease. J Am Soc Nephrol 16(2):520\u2013528. https:\/\/doi.org\/10.1681\/ASN.2004070602","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"3160_CR28","doi-asserted-by":"publisher","first-page":"2909","DOI":"10.1093\/ndt\/gfm286","volume":"22","author":"N Voormolen","year":"2007","unstructured":"Voormolen N et al (2007) High plasma phosphate as a risk factor for decline in renal function and mortality in pre-dialysis patients. Nephrol Dial Transpl 22(10):2909\u20132916. https:\/\/doi.org\/10.1093\/ndt\/gfm286","journal-title":"Nephrol Dial Transpl"},{"issue":"8","key":"3160_CR29","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","volume":"15","author":"GA Block","year":"2004","unstructured":"Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM (2004) Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 15(8):2208\u20132218. https:\/\/doi.org\/10.1097\/01.ASN.0000133041.27682.A2","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"3160_CR30","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1097\/01.asn.0000113243.24155.2f","volume":"15","author":"LA Stevens","year":"2004","unstructured":"Stevens LA, Djurdjev O, Cardew S, Cameron EC, Levin A (2004) Calcium, phosphate, and parathyroid hormone levels in combination and as a function of dialysis duration predict mortality: evidence for the complexity of the association between mineral metabolism and outcomes. J Am Soc Nephrol 15(3):770\u2013779. https:\/\/doi.org\/10.1097\/01.asn.0000113243.24155.2f","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"3160_CR31","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1053\/j.ajkd.2005.04.006","volume":"46","author":"A Rodriguez-Benot","year":"2005","unstructured":"Rodriguez-Benot A, Martin-Malo A, Alvarez-Lara MA, Rodriguez M, Aljama P (2005) Mild hyperphosphatemia and mortality in hemodialysis patients. Am J Kidney Dis 46(1):68\u201377. https:\/\/doi.org\/10.1053\/j.ajkd.2005.04.006","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"3160_CR32","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/sj.ki.5001514","volume":"70","author":"K Kalantar-Zadeh","year":"2006","unstructured":"Kalantar-Zadeh K et al (2006) Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients. Kidney Int 70(4):771\u2013780. https:\/\/doi.org\/10.1038\/sj.ki.5001514","journal-title":"Kidney Int"},{"issue":"1","key":"3160_CR33","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12882-024-03525-x","volume":"25","author":"Z Fan","year":"2024","unstructured":"Fan Z et al (2024) Relationship between serum phosphorus and mortality in non-dialysis chronic kidney disease patients: evidence from NHANES 2001\u20132018. BMC Nephrol 25(1):89. https:\/\/doi.org\/10.1186\/s12882-024-03525-x","journal-title":"BMC Nephrol"},{"issue":"10","key":"3160_CR34","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1093\/ndt\/gfaa054","volume":"35","author":"MB Lopes","year":"2020","unstructured":"Lopes MB et al (2020) Impact of longer term phosphorus control on cardiovascular mortality in hemodialysis patients using an area under the curve approach: results from the DOPPS. Nephrol Dial Transpl 35(10):1794\u20131801. https:\/\/doi.org\/10.1093\/ndt\/gfaa054","journal-title":"Nephrol Dial Transpl"},{"issue":"2","key":"3160_CR35","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1053\/j.ajkd.2015.01.009","volume":"66","author":"J Da","year":"2015","unstructured":"Da J et al (2015) Serum phosphorus and progression of CKD and mortality: A meta-analysis of cohort studies. Am J Kidney Dis 66(2):258\u2013265. https:\/\/doi.org\/10.1053\/j.ajkd.2015.01.009","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"3160_CR36","doi-asserted-by":"publisher","first-page":"883","DOI":"10.2215\/CJN.07810910","volume":"6","author":"A Bellasi","year":"2011","unstructured":"Bellasi A et al (2011) Chronic kidney disease progression and outcome according to serum phosphorus in mild-to-moderate kidney dysfunction. Clin J Am Soc Nephrol 6(4):883\u2013891. https:\/\/doi.org\/10.2215\/CJN.07810910","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"3160_CR37","doi-asserted-by":"publisher","first-page":"825","DOI":"10.2215\/CJN.02101205","volume":"1","author":"S Schwarz","year":"2006","unstructured":"Schwarz S, Trivedi BK, Kalantar-Zadeh K, Kovesdy CP (2006) Association of disorders in mineral metabolism with progression of chronic kidney disease. Clin J Am Soc Nephrol 1(4):825\u2013831. https:\/\/doi.org\/10.2215\/CJN.02101205","journal-title":"Clin J Am Soc Nephrol"},{"issue":"10","key":"3160_CR38","doi-asserted-by":"publisher","first-page":"2928","DOI":"10.1681\/ASN.2005101101","volume":"17","author":"KC Norris","year":"2006","unstructured":"Norris KC et al (2006) Baseline predictors of renal disease progression in the African American study of hypertension and kidney disease. J Am Soc Nephrol 17(10):2928\u20132936. https:\/\/doi.org\/10.1681\/ASN.2005101101","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"3160_CR39","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1681\/ASN.2011020175","volume":"22","author":"C Zoccali","year":"2011","unstructured":"Zoccali C et al (2011) Phosphate may promote CKD progression and attenuate renoprotective effect of ACE inhibition. J Am Soc Nephrol 22(10):1923\u20131930. https:\/\/doi.org\/10.1681\/ASN.2011020175","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"3160_CR40","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1053\/j.ajkd.2017.04.014","volume":"70","author":"B Merhi","year":"2017","unstructured":"Merhi B et al (2017) Serum phosphorus and risk of cardiovascular disease, all-cause mortality, or graft failure in kidney transplant recipients: An ancillary study of the FAVORIT trial cohort. Am J Kidney Dis 70(3):377\u2013385. https:\/\/doi.org\/10.1053\/j.ajkd.2017.04.014","journal-title":"Am J Kidney Dis"},{"issue":"10","key":"3160_CR41","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1681\/ASN.V1101169","volume":"1","author":"SA Brown","year":"1991","unstructured":"Brown SA, Crowell WA, Barsanti JA, White JV, Finco DR (1991) Beneficial effects of dietary mineral restriction in dogs with marked reduction of functional renal mass. J Am Soc Nephrol 1(10):1169\u20131179. https:\/\/doi.org\/10.1681\/ASN.V1101169","journal-title":"J Am Soc Nephrol"},{"key":"3160_CR42","doi-asserted-by":"crossref","unstructured":"Finco DR, Brown SA, Crowell WA, Groves CA, Duncan JR, Barsanti JA (1992) Effects of phosphorus\/calcium-restricted and phosphorus\/calcium-replete 32% protein diets in dogs with chronic renal failure. Am J Vet Res 53(1):157\u201363. [Online]. Available: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1539911","DOI":"10.2460\/ajvr.1992.53.01.157"},{"key":"3160_CR43","doi-asserted-by":"publisher","unstructured":"Martinez-Arias L et al (eds) (2021). Contribucion de fosforo y PTH al desarrollo de hipertrofia y fibrosis cardiaca en un modelo experimental de insuficiencia renal cronica. https:\/\/doi.org\/10.1016\/j.nefro.2021.02.001","DOI":"10.1016\/j.nefro.2021.02.001"},{"key":"3160_CR44","doi-asserted-by":"publisher","unstructured":"Duayer IF et al (2021) The protein-independent role of phosphate in the progression of chronic kidney disease. Toxins (Basel) 13(7). https:\/\/doi.org\/10.3390\/toxins13070503","DOI":"10.3390\/toxins13070503"},{"issue":"6","key":"3160_CR45","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1111\/j.1523-1755.2004.66013.x","volume":"66","author":"KR dos Neves","year":"2004","unstructured":"Neves KR, Graciolli FG, dos Reis LM, Pasqualucci CA, Moyses RM, Jorgetti V (2004) Adverse effects of hyperphosphatemia on myocardial hypertrophy, renal function, and bone in rats with renal failure. Kidney Int 66(6):2237\u20132244. https:\/\/doi.org\/10.1111\/j.1523-1755.2004.66013.x","journal-title":"Kidney Int"},{"issue":"6","key":"3160_CR46","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1038\/ki.2013.213","volume":"84","author":"JL Finch","year":"2013","unstructured":"Finch JL et al (2013) Phosphate restriction significantly reduces mortality in uremic rats with established vascular calcification. Kidney Int 84(6):1145\u20131153. https:\/\/doi.org\/10.1038\/ki.2013.213","journal-title":"Kidney Int"},{"issue":"2","key":"3160_CR47","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/ki.2008.456","volume":"75","author":"SM Moe","year":"2009","unstructured":"Moe SM et al (2009) A rat model of chronic kidney disease-mineral bone disorder. Kidney Int 75(2):176\u2013184. https:\/\/doi.org\/10.1038\/ki.2008.456","journal-title":"Kidney Int"},{"issue":"5","key":"3160_CR48","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1002\/jcp.30700","volume":"237","author":"T Kulesza","year":"2022","unstructured":"Kulesza T et al (2022) Hyperglycemic environment disrupts phosphate transporter function and promotes calcification processes in podocytes and isolated glomeruli. J Cell Physiol 237(5):2478\u20132491. https:\/\/doi.org\/10.1002\/jcp.30700","journal-title":"J Cell Physiol"},{"issue":"4","key":"3160_CR49","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/ki.2013.194","volume":"84","author":"S Zhang","year":"2013","unstructured":"Zhang S et al (2013) Dietary phosphate restriction suppresses phosphaturia but does not prevent FGF23 elevation in a mouse model of chronic kidney disease. Kidney Int 84(4):713\u2013721. https:\/\/doi.org\/10.1038\/ki.2013.194","journal-title":"Kidney Int"},{"issue":"9","key":"3160_CR50","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.34067\/KID.0007352021","volume":"3","author":"JR Stubbs","year":"2022","unstructured":"Stubbs JR et al (2022) Critical role of osteopontin in maintaining urinary phosphate solubility in CKD. Kidney360 3(9):1578\u20131589. https:\/\/doi.org\/10.34067\/KID.0007352021","journal-title":"Kidney360"},{"issue":"6","key":"3160_CR51","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/ki.1980.85","volume":"17","author":"LL Haut","year":"1980","unstructured":"Haut LL, Alfrey AC, Guggenheim S, Buddington B, Schrier N (1980) Renal toxicity of phosphate in rats. Kidney Int 17(6):722\u2013731. https:\/\/doi.org\/10.1038\/ki.1980.85","journal-title":"Kidney Int"},{"issue":"3","key":"3160_CR52","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1056\/NEJM197801192980302","volume":"298","author":"LS Ibels","year":"1978","unstructured":"Ibels LS, Alfrey AC, Haut L, Huffer WE (1978) Preservation of function in experimental renal disease by dietary restriction of phosphate. N Engl J Med 298(3):122\u2013126. https:\/\/doi.org\/10.1056\/NEJM197801192980302","journal-title":"N Engl J Med"},{"issue":"5","key":"3160_CR53","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1002\/2211-5463.12845","volume":"10","author":"Y Hirano","year":"2020","unstructured":"Hirano Y, Kurosu H, Shiizaki K, Iwazu Y, Tsuruoka S, Kuro OM (2020) Interleukin-36alpha as a potential biomarker for renal tubular damage induced by dietary phosphate load. FEBS Open Bio 10(5):894\u2013903. https:\/\/doi.org\/10.1002\/2211-5463.12845","journal-title":"FEBS Open Bio"},{"issue":"1","key":"3160_CR54","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/ki.1982.129","volume":"22","author":"L Gimenez","year":"1982","unstructured":"Gimenez L, Walker WG, Tew WP, Hermann JA (1982) Prevention of phosphate-induced progression of uremia in rats by 3-phosphocitric acid. Kidney Int 22(1):36\u201341. https:\/\/doi.org\/10.1038\/ki.1982.129","journal-title":"Kidney Int"},{"issue":"1","key":"3160_CR55","doi-asserted-by":"publisher","first-page":"13701","DOI":"10.1038\/s41598-018-32065-2","volume":"8","author":"R Santamaria","year":"2018","unstructured":"Santamaria R et al (2018) Increased phosphaturia accelerates the decline in renal function: A search for mechanisms. Sci Rep 8(1):13701. https:\/\/doi.org\/10.1038\/s41598-018-32065-2","journal-title":"Sci Rep"},{"key":"3160_CR56","doi-asserted-by":"publisher","first-page":"260106022112222","DOI":"10.1177\/02601060221122223","volume":"29","author":"K Mori","year":"2022","unstructured":"Mori K, Katsumata SI, Miyajima K, Uno K, Matsuzaki H (2022) Effects of dietary phosphorus concentration and phosphate salt form on renal tubule function in unilateral nephrectomized rats. Nutr Health Aug 29:2601060221122223. https:\/\/doi.org\/10.1177\/02601060221122223","journal-title":"Nutr Health"},{"key":"3160_CR57","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.3389\/fphar.2020.01273","volume":"11","author":"J Maique","year":"2020","unstructured":"Maique J et al (2020) High Phosphate Induces and Klotho Attenuates Kidney Epithelial Senescence and Fibrosis. Front Pharmacol 11:1273. https:\/\/doi.org\/10.3389\/fphar.2020.01273","journal-title":"Front Pharmacol"},{"issue":"10","key":"3160_CR58","doi-asserted-by":"publisher","first-page":"4506","DOI":"10.1172\/JCI128503","volume":"129","author":"JA Torres","year":"2019","unstructured":"Torres JA et al (2019) Crystal deposition triggers tubule dilation that accelerates cystogenesis in polycystic kidney disease. J Clin Invest 129(10):4506\u20134522. https:\/\/doi.org\/10.1172\/JCI128503","journal-title":"J Clin Invest"},{"issue":"12","key":"3160_CR59","doi-asserted-by":"publisher","first-page":"F1418","DOI":"10.1152\/ajprenal.00633.2013","volume":"306","author":"S Yamada","year":"2014","unstructured":"Yamada S et al (2014) Phosphate overload directly induces systemic inflammation and malnutrition as well as vascular calcification in uremia. Am J Physiol Ren Physiol 306(12):F1418\u2013F1428. https:\/\/doi.org\/10.1152\/ajprenal.00633.2013","journal-title":"Am J Physiol Ren Physiol"},{"issue":"1","key":"3160_CR60","doi-asserted-by":"publisher","first-page":"2228920","DOI":"10.1080\/0886022X.2023.2228920","volume":"45","author":"X Yang","year":"2023","unstructured":"Yang X et al (2023) Vascular, valvular and kidney calcification manifested in mouse models of adenine-induced chronic kidney disease. Ren Fail 45(1):2228920. https:\/\/doi.org\/10.1080\/0886022X.2023.2228920","journal-title":"Ren Fail"},{"key":"3160_CR61","doi-asserted-by":"publisher","unstructured":"Shiizaki K et al (2021) Calcium phosphate microcrystals in the renal tubular fluid accelerate chronic kidney disease progression. J Clin Invest 131(16). https:\/\/doi.org\/10.1172\/JCI145693","DOI":"10.1172\/JCI145693"},{"key":"3160_CR62","doi-asserted-by":"publisher","unstructured":"Biruete A et al (2023) The dietary fermentable fiber inulin alters the intestinal microbiome and improves chronic kidney disease mineral-bone disorder in a rat model of CKD. bioRxiv Jan 31. https:\/\/doi.org\/10.1101\/2023.01.29.526093","DOI":"10.1101\/2023.01.29.526093"},{"issue":"4","key":"3160_CR63","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1525-139X.2007.00309.x","volume":"20","author":"J Uribarri","year":"2007","unstructured":"Uribarri J (2007) Phosphorus homeostasis in normal health and in chronic kidney disease patients with special emphasis on dietary phosphorus intake. Semin Dial 20(4):295\u2013301. https:\/\/doi.org\/10.1111\/j.1525-139X.2007.00309.x","journal-title":"Semin Dial"},{"issue":"8","key":"3160_CR64","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1007\/s00424-022-02691-x","volume":"474","author":"I Rubio-Aliaga","year":"2022","unstructured":"Rubio-Aliaga I, Krapf R (2022) Phosphate intake, hyperphosphatemia, and kidney function. Pflugers Arch 474(8):935\u2013947. https:\/\/doi.org\/10.1007\/s00424-022-02691-x","journal-title":"Pflugers Arch"},{"key":"3160_CR65","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s12882-015-0118-1","volume":"16","author":"T Kawasaki","year":"2015","unstructured":"Kawasaki T, Maeda Y, Matsuki H, Matsumoto Y, Akazawa M, Kuyama T (2015) Urinary phosphorus excretion per creatinine clearance as a prognostic marker for progression of chronic kidney disease: a retrospective cohort study. BMC Nephrol 16:116. https:\/\/doi.org\/10.1186\/s12882-015-0118-1","journal-title":"BMC Nephrol"},{"issue":"1","key":"3160_CR66","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1053\/j.jrn.2024.06.009","volume":"35","author":"S Mori","year":"2025","unstructured":"Mori S et al (2025) Estimated proximal tubule fluid phosphate concentration and renal tubular damage biomarkers in early stages of chronic kidney disease. J Ren Nutr 35(1):81\u201389. https:\/\/doi.org\/10.1053\/j.jrn.2024.06.009","journal-title":"J Ren Nutr"},{"issue":"7","key":"3160_CR67","doi-asserted-by":"publisher","first-page":"e22407","DOI":"10.1096\/fj.202200167RR","volume":"36","author":"B Richter","year":"2022","unstructured":"Richter B et al (2022) High phosphate-induced progressive proximal tubular injury is associated with the activation of Stat3\/Kim-1 signaling pathway and macrophage recruitment. FASEB J 36(7):e22407. https:\/\/doi.org\/10.1096\/fj.202200167RR","journal-title":"FASEB J"},{"issue":"5","key":"3160_CR68","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1053\/j.jrn.2021.10.009","volume":"32","author":"ND Toussaint","year":"2022","unstructured":"Toussaint ND et al (2022) Relationship between urinary phosphate and all-cause and cardiovascular mortality in a national population-based longitudinal cohort study. J Ren Nutr 32(5):510\u2013519. https:\/\/doi.org\/10.1053\/j.jrn.2021.10.009","journal-title":"J Ren Nutr"},{"key":"3160_CR69","doi-asserted-by":"publisher","unstructured":"Suh SH et al (2023) Urinary phosphorus excretion and cardiovascular outcomes in patients with pre-dialysis chronic kidney disease: The KNOW-CKD study. Nutrients 15(10) https:\/\/doi.org\/10.3390\/nu15102267","DOI":"10.3390\/nu15102267"},{"issue":"5","key":"3160_CR70","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1038\/ki.1989.281","volume":"36","author":"K Lau","year":"1989","unstructured":"Lau K (1989) Phosphate excess and progressive renal failure: the precipitation-calcification hypothesis. Kidney Int 36(5):918\u2013937. https:\/\/doi.org\/10.1038\/ki.1989.281","journal-title":"Kidney Int"},{"issue":"12","key":"3160_CR71","doi-asserted-by":"publisher","first-page":"2942","DOI":"10.1016\/j.ekir.2021.09.003","volume":"6","author":"MA Perazella","year":"2021","unstructured":"Perazella MA, Herlitz LC (2021) The Crystalline Nephropathies. Kidney Int Rep 6(12):2942\u20132957. https:\/\/doi.org\/10.1016\/j.ekir.2021.09.003","journal-title":"Kidney Int Rep"},{"issue":"1","key":"3160_CR72","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/ki.2008.450","volume":"75","author":"BA De Vervaet","year":"2009","unstructured":"Vervaet BA, Verhulst A, Dauwe SE, De Broe ME (2009) D\u2019Haese, An active renal crystal clearance mechanism in rat and man. Kidney Int 75(1):41\u201351. https:\/\/doi.org\/10.1038\/ki.2008.450","journal-title":"Kidney Int"},{"key":"3160_CR73","doi-asserted-by":"publisher","first-page":"15272","DOI":"10.1038\/srep15272","volume":"5","author":"TY Wong","year":"2015","unstructured":"Wong TY et al (2015) Detection and characterization of mineralo-organic nanoparticles in human kidneys. Sci Rep 5:15272. https:\/\/doi.org\/10.1038\/srep15272","journal-title":"Sci Rep"},{"key":"3160_CR74","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s41420-019-0138-x","volume":"5","author":"G Priante","year":"2019","unstructured":"Priante G, Ceol M, Gianesello L, Furlan C, Prete DD, Anglani F (2019) Human proximal tubular cells can form calcium phosphate deposits in osteogenic culture: role of cell death and osteoblast-like transdifferentiation. Cell Death Discov 5:57. https:\/\/doi.org\/10.1038\/s41420-019-0138-x","journal-title":"Cell Death Discov"},{"key":"3160_CR75","doi-asserted-by":"publisher","unstructured":"Moe OW (2021) A generic crystallopathic model for chronic kidney disease progression. J Clin Invest 131(16). https:\/\/doi.org\/10.1172\/JCI151858","DOI":"10.1172\/JCI151858"},{"issue":"6","key":"3160_CR76","doi-asserted-by":"publisher","first-page":"F751","DOI":"10.1152\/ajprenal.00329.2012","volume":"304","author":"I Matsui","year":"2013","unstructured":"Matsui I et al (2013) Retention of fetuin-A in renal tubular lumen protects the kidney from nephrocalcinosis in rats. Am J Physiol Ren Physiol 304(6):F751\u2013F760. https:\/\/doi.org\/10.1152\/ajprenal.00329.2012","journal-title":"Am J Physiol Ren Physiol"},{"issue":"1","key":"3160_CR77","doi-asserted-by":"publisher","first-page":"14023","DOI":"10.1038\/s41598-019-50669-0","volume":"9","author":"A Taylor","year":"2019","unstructured":"Taylor A et al (2019) FGFR4 does not contribute to progression of chronic kidney disease. Sci Rep 9(1):14023. https:\/\/doi.org\/10.1038\/s41598-019-50669-0","journal-title":"Sci Rep"},{"issue":"6","key":"3160_CR78","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1016\/S0002-9440(10)64482-3","volume":"161","author":"SA Steitz","year":"2002","unstructured":"Steitz SA et al (Dec 2002) Osteopontin inhibits mineral deposition and promotes regression of ectopic calcification. Am J Pathol 161(6):2035\u20132046. https:\/\/doi.org\/10.1016\/S0002-9440(10)64482-3","journal-title":"Am J Pathol"},{"issue":"15","key":"3160_CR79","doi-asserted-by":"publisher","first-page":"8352","DOI":"10.1073\/pnas.140021997","volume":"97","author":"GR Beck Jr.","year":"2000","unstructured":"Beck GR Jr., Zerler B, Moran E (2000) Phosphate is a specific signal for induction of osteopontin gene expression. Proc Natl Acad Sci U S A 97(15):8352\u20138357. https:\/\/doi.org\/10.1073\/pnas.140021997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3160_CR80","doi-asserted-by":"publisher","first-page":"41921","DOI":"10.1074\/jbc.M304470200","volume":"278","author":"GR Beck Jr.","year":"2003","unstructured":"Beck GR Jr., Knecht N (2003) Osteopontin regulation by inorganic phosphate is ERK1\/2-, protein kinase C-, and proteasome-dependent. J Biol Chem 278:41921\u201341929. https:\/\/doi.org\/10.1074\/jbc.M304470200","journal-title":"J Biol Chem"},{"issue":"4","key":"3160_CR81","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1359\/jbmr.2003.18.4.644","volume":"18","author":"H Chau","year":"2003","unstructured":"Chau H, El-Maadawy S, McKee MD, Tenenhouse HS (2003) Renal calcification in mice homozygous for the disrupted type IIa Na\/Pi cotransporter gene Npt2. J Bone Min Res 18(4):644\u2013657. https:\/\/doi.org\/10.1359\/jbmr.2003.18.4.644","journal-title":"J Bone Min Res"},{"issue":"5","key":"3160_CR82","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/j.kint.2015.12.046","volume":"89","author":"NJ Paloian","year":"2016","unstructured":"Paloian NJ, Leaf EM, Giachelli CM (2016) Osteopontin protects against high phosphate-induced nephrocalcinosis and vascular calcification. Kidney Int 89(5):1027\u20131036. https:\/\/doi.org\/10.1016\/j.kint.2015.12.046","journal-title":"Kidney Int"},{"issue":"2","key":"3160_CR83","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/ki.1994.67","volume":"45","author":"CM Giachelli","year":"1994","unstructured":"Giachelli CM et al (1994) Osteopontin expression in angiotensin II-induced tubulointerstitial nephritis. Kidney Int 45(2):515\u2013524. https:\/\/doi.org\/10.1038\/ki.1994.67","journal-title":"Kidney Int"},{"issue":"4","key":"3160_CR84","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1002\/cbic.200800719","volume":"10","author":"CN Rochette","year":"2009","unstructured":"Rochette CN, Rosenfeldt S, Heiss A, Narayanan T, Ballauff M, Jahnen-Dechent W (2009) A shielding topology stabilizes the early stage protein-mineral complexes of fetuin-A and calcium phosphate: a time-resolved small-angle X-ray study. ChemBioChem 10(4):735\u2013740. https:\/\/doi.org\/10.1002\/cbic.200800719","journal-title":"ChemBioChem"},{"issue":"12","key":"3160_CR85","doi-asserted-by":"publisher","first-page":"3986","DOI":"10.1016\/j.bpj.2010.10.030","volume":"99","author":"A Heiss","year":"2010","unstructured":"Heiss A, Pipich V, Jahnen-Dechent W, Schwahn D (2010) Fetuin-A is a mineral carrier protein: small angle neutron scattering provides new insight on Fetuin-A controlled calcification inhibition. Biophys J 99(12):3986\u20133995. https:\/\/doi.org\/10.1016\/j.bpj.2010.10.030","journal-title":"Biophys J"},{"issue":"8","key":"3160_CR86","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1007\/s00424-022-02688-6","volume":"474","author":"S Rudloff","year":"2022","unstructured":"Rudloff S, Jahnen-Dechent W, Huynh-Do U (2022) Tissue chaperoning-the expanded functions of fetuin-A beyond inhibition of systemic calcification. Pflugers Arch 474(8):949\u2013962. https:\/\/doi.org\/10.1007\/s00424-022-02688-6","journal-title":"Pflugers Arch"},{"issue":"4","key":"3160_CR87","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.tcm.2007.02.005","volume":"17","author":"R Westenfeld","year":"2007","unstructured":"Westenfeld R, Jahnen-Dechent W, Ketteler M (2007) Vascular calcification and fetuin-A deficiency in chronic kidney disease. Trends Cardiovasc Med 17(4):124\u2013128. https:\/\/doi.org\/10.1016\/j.tcm.2007.02.005","journal-title":"Trends Cardiovasc Med"},{"issue":"2","key":"3160_CR88","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/1744-9987.14091","volume":"28","author":"R Olmaz","year":"2024","unstructured":"Olmaz R, Selen T, Gungor O (2024) Vascular calcification inhibitors and cardiovascular events in peritoneal dialysis patients. Ther Apher Dial 28(2):169\u2013181. https:\/\/doi.org\/10.1111\/1744-9987.14091","journal-title":"Ther Apher Dial"},{"key":"3160_CR89","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1093\/ndt\/gfm094","volume":"22","author":"R Westenfeld","year":"2007","unstructured":"Westenfeld R et al (2007) Fetuin-A (AHSG) prevents extraosseous calcification induced by uraemia and phosphate challenge in mice. Nephrol Dial Transpl 22:1537\u20131546. https:\/\/doi.org\/10.1093\/ndt\/gfm094","journal-title":"Nephrol Dial Transpl"},{"issue":"5 Pt 2","key":"3160_CR90","doi-asserted-by":"publisher","first-page":"F705","DOI":"10.1152\/ajprenal.1985.248.5.F705","volume":"248","author":"M Amstutz","year":"1985","unstructured":"Amstutz M, Mohrmann M, Gmaj P, Murer H (1985) Effect of pH on phosphate transport in rat renal brush border membrane vesicles. Am J Physiol 248(5 Pt 2):F705\u2013F710. https:\/\/doi.org\/10.1152\/ajprenal.1985.248.5.F705","journal-title":"Am J Physiol"},{"issue":"1","key":"3160_CR91","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1152\/physrev.00008.2019","volume":"101","author":"N Hernando","year":"2021","unstructured":"Hernando N, Gagnon K, Lederer E (2021) Phosphate transport in epithelial and nonepithelial tissue. Physiol Rev 101(1):1\u201335. https:\/\/doi.org\/10.1152\/physrev.00008.2019","journal-title":"Physiol Rev"},{"issue":"5","key":"3160_CR92","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1046\/j.1523-1755.1998.00901.x","volume":"53","author":"PM Ambuhl","year":"1998","unstructured":"Ambuhl PM, Zajicek HK, Wang H, Puttaparthi K, Levi M (1998) Regulation of renal phosphate transport by acute and chronic metabolic acidosis in the rat. Kidney Int 53(5):1288\u20131298. https:\/\/doi.org\/10.1046\/j.1523-1755.1998.00901.x","journal-title":"Kidney Int"},{"issue":"11","key":"3160_CR93","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.2215\/CJN.03730410","volume":"5","author":"YW Chiu","year":"2010","unstructured":"Chiu YW, Adler S, Budoff M, Takasu J, Ashai J, Mehrotra R (2010) Prevalence and prognostic significance of renal artery calcification in patients with diabetes and proteinuria. Clin J Am Soc Nephrol 5(11):2093\u20132100. https:\/\/doi.org\/10.2215\/CJN.03730410","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"3160_CR94","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1111\/j.1523-1755.2004.00645.x","volume":"65","author":"BI Freedman","year":"2004","unstructured":"Freedman BI et al (2004) Renal artery calcified plaque associations with subclinical renal and cardiovascular disease. Kidney Int 65(6):2262\u20132267. https:\/\/doi.org\/10.1111\/j.1523-1755.2004.00645.x","journal-title":"Kidney Int"},{"issue":"4","key":"3160_CR95","doi-asserted-by":"publisher","first-page":"F848","DOI":"10.1152\/ajprenal.00334.2010","volume":"300","author":"S Sekiguchi","year":"2011","unstructured":"Sekiguchi S et al (2011) Phosphate overload induces podocyte injury via type III Na-dependent phosphate transporter. Am J Physiol Ren Physiol 300(4):F848\u2013F856. https:\/\/doi.org\/10.1152\/ajprenal.00334.2010","journal-title":"Am J Physiol Ren Physiol"},{"issue":"4","key":"3160_CR96","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1080\/01926230490452490","volume":"32","author":"N Tsuchiya","year":"2004","unstructured":"Tsuchiya N, Matsushima S, Takasu N, Kyokawa Y, Torii M (2004) Glomerular calcification induced by bolus injection with dibasic sodium phosphate solution in Sprague-Dawley rats. Toxicol Pathol 32(4):408\u2013412. https:\/\/doi.org\/10.1080\/01926230490452490","journal-title":"Toxicol Pathol"},{"issue":"10","key":"3160_CR97","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1007\/s00467-006-0195-2","volume":"21","author":"S Feinstein","year":"2006","unstructured":"Feinstein S, Becker-Cohen R, Rinat C, Frishberg Y (2006) Hyperphosphatemia is prevalent among children with nephrotic syndrome and normal renal function. Pediatr Nephrol 21(10):1406\u20131412. https:\/\/doi.org\/10.1007\/s00467-006-0195-2","journal-title":"Pediatr Nephrol"},{"issue":"4","key":"3160_CR98","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1111\/nep.13001","volume":"23","author":"AK Yadav","year":"2018","unstructured":"Yadav AK, Ramachandran R, Aggarwal A, Kumar V, Gupta KL, Jha V (2018) Fibroblast growth factor 23 in untreated nephrotic syndrome. Nephrol (Carlton) 23(4):362\u2013365. https:\/\/doi.org\/10.1111\/nep.13001","journal-title":"Nephrol (Carlton)"},{"issue":"2","key":"3160_CR99","doi-asserted-by":"publisher","first-page":"390","DOI":"10.3892\/etm.2023.12089","volume":"26","author":"D Liu","year":"2023","unstructured":"Liu D, Yang F, Zhang S, Guo Z, Peng S (2023) Significance of changes in FGF23 levels in childhood primary nephrotic syndrome and children who progress to end\u2013stage renal disease. Exp Ther Med 26(2):390. https:\/\/doi.org\/10.3892\/etm.2023.12089","journal-title":"Exp Ther Med"},{"key":"3160_CR100","doi-asserted-by":"publisher","first-page":"9698367","DOI":"10.1155\/2019\/9698367","volume":"2019","author":"A Pukajlo-Marczyk","year":"2019","unstructured":"Pukajlo-Marczyk A, Jakubowska A, Bargenda-Lange A, Kilis-Pstrusinska K, Zwolinska D (2019) Assessment of the Concentration of Bone Metabolism Markers: Sclerostin and FGF-23 in Children with Idiopathic Nephrotic Syndrome Treated with Glucocorticosteroids. Dis Markers 2019:9698367. https:\/\/doi.org\/10.1155\/2019\/9698367","journal-title":"Dis Markers"},{"issue":"5","key":"3160_CR101","doi-asserted-by":"publisher","first-page":"727","DOI":"10.2215\/CJN.10331011","volume":"7","author":"S Lundberg","year":"2012","unstructured":"Lundberg S, Qureshi AR, Olivecrona S, Gunnarsson I, Jacobson SH, Larsson TE (2012) FGF23, albuminuria, and disease progression in patients with chronic IgA nephropathy. Clin J Am Soc Nephrol 7(5):727\u2013734. https:\/\/doi.org\/10.2215\/CJN.10331011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"7","key":"3160_CR102","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1681\/ASN.2014010104","volume":"26","author":"S de Seigneux","year":"2015","unstructured":"de Seigneux S et al (2015) Proteinuria increases plasma phosphate by altering its tubular handling. J Am Soc Nephrol 26(7):1608\u20131618. https:\/\/doi.org\/10.1681\/ASN.2014010104","journal-title":"J Am Soc Nephrol"},{"key":"3160_CR103","doi-asserted-by":"publisher","first-page":"3609645","DOI":"10.1155\/2018\/3609645","volume":"2018","author":"FC Catia","year":"2018","unstructured":"Catia F C et al (2018) Calcitriol Prevents Cardiovascular Repercussions in Puromycin Aminonucleoside-Induced Nephrotic Syndrome. Biomed Res Int 2018:3609645. https:\/\/doi.org\/10.1155\/2018\/3609645","journal-title":"Biomed Res Int"},{"issue":"12","key":"3160_CR104","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1038\/sj.ki.5002204","volume":"71","author":"M Moreira-Rodrigues","year":"2007","unstructured":"Moreira-Rodrigues M et al (2007) Cardiac remodeling and dysfunction in nephrotic syndrome. Kidney Int 71(12):1240\u20131248. https:\/\/doi.org\/10.1038\/sj.ki.5002204","journal-title":"Kidney Int"},{"issue":"2","key":"3160_CR105","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1096\/fj.201900893R","volume":"34","author":"V Delitsikou","year":"2020","unstructured":"Delitsikou V et al (2020) Klotho regulation by albuminuria is dependent on ATF3 and endoplasmic reticulum stress. FASEB J 34(2):2087\u20132104. https:\/\/doi.org\/10.1096\/fj.201900893R","journal-title":"FASEB J"},{"key":"3160_CR106","doi-asserted-by":"publisher","unstructured":"Christov M et al (2018) Inducible podocyte-specific deletion of CTCF drives progressive kidney disease and bone abnormalities. JCI Insight 3(4). https:\/\/doi.org\/10.1172\/jci.insight.95091","DOI":"10.1172\/jci.insight.95091"},{"issue":"2","key":"3160_CR107","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1159\/000497118","volume":"142","author":"A Maeda","year":"2019","unstructured":"Maeda A, Fukushima N, Horiba N, Segawa H, Miyamoto KI (2019) The role of extracellular phosphate levels on kidney disease progression in a podocyte injury mouse model. Nephron 142(2):135\u2013146. https:\/\/doi.org\/10.1159\/000497118","journal-title":"Nephron"},{"key":"3160_CR108","doi-asserted-by":"publisher","unstructured":"Fajol A et al (2025) Nephrotic syndrome in mice elevates FGF23 levels and leads to cardiac hypertrophy in the absence of hyperphosphatemia. Nephrol Dial Transpl. https:\/\/doi.org\/10.1093\/ndt\/gfaf272","DOI":"10.1093\/ndt\/gfaf272"},{"key":"3160_CR109","doi-asserted-by":"publisher","unstructured":"Kuro OM (2023) Calcium phosphate microcrystallopathy as a paradigm of chronic kidney disease progression. Curr Opin Nephrol Hypertens. https:\/\/doi.org\/10.1097\/MNH.0000000000000890","DOI":"10.1097\/MNH.0000000000000890"},{"issue":"1","key":"3160_CR110","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3265\/Nefrologia.pre2013.Dec.12385","volume":"34","author":"M Kuro-o","year":"2014","unstructured":"Kuro-o M (2014) Calciprotein particle (CPP): a true culprit of phosphorus. woes? Nefrologia 34(1):1\u20134 10.3265\/Nefrologia.pre2013.Dec.12385 https:\/\/doi.org\/10.3265\/Nefrologia.pre2013.Dec.12385","journal-title":"Nefrologia"},{"key":"3160_CR111","doi-asserted-by":"publisher","unstructured":"Smith ER, Holt SG (2025) The formation and function of calciprotein particles. Pflugers Arch. https:\/\/doi.org\/10.1007\/s00424-025-03083-7","DOI":"10.1007\/s00424-025-03083-7"},{"issue":"4","key":"3160_CR112","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1097\/MNH.0000000000000609","volume":"29","author":"ER Smith","year":"2020","unstructured":"Smith ER, Hewitson TD, Jahnen-Dechent W (2020) Calciprotein particles: mineral behaving badly? Curr Opin Nephrol Hypertens 29(4):378\u2013386. https:\/\/doi.org\/10.1097\/MNH.0000000000000609","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"4","key":"3160_CR113","doi-asserted-by":"publisher","first-page":"F622","DOI":"10.1152\/ajprenal.00239.2023","volume":"326","author":"LW Zeper","year":"2024","unstructured":"Zeper LW et al (2024) Liver and spleen predominantly mediate calciprotein particle clearance in a rat model of chronic kidney disease. Am J Physiol Ren Physiol 326(4):F622\u2013F634. https:\/\/doi.org\/10.1152\/ajprenal.00239.2023","journal-title":"Am J Physiol Ren Physiol"},{"key":"3160_CR114","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.3389\/fimmu.2018.01991","volume":"9","author":"S Koppert","year":"2018","unstructured":"Koppert S et al (2018) Cellular Clearance and Biological Activity of Calciprotein Particles Depend on Their Maturation State and Crystallinity. Front Immunol 9:1991. https:\/\/doi.org\/10.3389\/fimmu.2018.01991","journal-title":"Front Immunol"},{"issue":"5","key":"3160_CR115","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1093\/ndt\/gfr609","volume":"27","author":"ER Smith","year":"2012","unstructured":"Smith ER, Ford ML, Tomlinson LA, Rajkumar C, McMahon LP, Holt SG (2012) Phosphorylated fetuin-A-containing calciprotein particles are associated with aortic stiffness and a procalcific milieu in patients with pre-dialysis CKD. Nephrol Dial Transpl 27(5):1957\u20131966. https:\/\/doi.org\/10.1093\/ndt\/gfr609","journal-title":"Nephrol Dial Transpl"},{"issue":"11","key":"3160_CR116","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1681\/ASN.2009090944","volume":"21","author":"T Hamano","year":"2010","unstructured":"Hamano T et al (2010) Fetuin-mineral complex reflects extraosseous calcification stress in CKD. J Am Soc Nephrol 21(11):1998\u20132007. https:\/\/doi.org\/10.1681\/ASN.2009090944","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"3160_CR117","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1038\/ki.2013.271","volume":"85","author":"Y Fang","year":"2014","unstructured":"Fang Y, Ginsberg C, Sugatani T, Monier-Faugere MC, Malluche H, Hruska KA (2014) Early chronic kidney disease-mineral bone disorder stimulates vascular calcification. Kidney Int 85(1):142\u2013150. https:\/\/doi.org\/10.1038\/ki.2013.271","journal-title":"Kidney Int"},{"key":"3160_CR118","doi-asserted-by":"publisher","unstructured":"Chen W et al (2018) Patients with advanced chronic kidney disease and vascular calcification have a large hydrodynamic radius of secondary calciprotein particles. Nephrol Dial Transpl. https:\/\/doi.org\/10.1093\/ndt\/gfy117","DOI":"10.1093\/ndt\/gfy117"},{"issue":"4","key":"3160_CR119","doi-asserted-by":"publisher","first-page":"e60904","DOI":"10.1371\/journal.pone.0060904","volume":"8","author":"ER Smith","year":"2013","unstructured":"Smith ER, Hanssen E, McMahon LP, Holt SG (2013) Fetuin-A-containing calciprotein particles reduce mineral stress in the macrophage. PLoS ONE 8(4):e60904. https:\/\/doi.org\/10.1371\/journal.pone.0060904","journal-title":"PLoS ONE"},{"key":"3160_CR120","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.atherosclerosis.2016.05.044","volume":"251","author":"P Aghagolzadeh","year":"2016","unstructured":"Aghagolzadeh P et al (2016) Calcification of vascular smooth muscle cells is induced by secondary calciprotein particles and enhanced by tumor necrosis factor-alpha. Atherosclerosis 251:404\u2013414. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2016.05.044","journal-title":"Atherosclerosis"},{"key":"3160_CR121","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1159\/000526609","volume":"53","author":"MK Tiong","year":"2022","unstructured":"Tiong MK, Holt SG, Ford ML, Smith ER (2022) Serum Calciprotein Monomers and Chronic Kidney Disease Progression. Am J Nephrol 53:11\u201312. https:\/\/doi.org\/10.1159\/000526609","journal-title":"Am J Nephrol"},{"issue":"4","key":"3160_CR122","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1097\/MNH.0000000000000890","volume":"32","author":"OM Kuro","year":"2023","unstructured":"Kuro OM (2023) Calcium phosphate microcrystallopathy as a paradigm of chronic kidney disease progression. Curr Opin Nephrol Hypertens 32(4):344\u2013351. https:\/\/doi.org\/10.1097\/MNH.0000000000000890","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"7","key":"3160_CR123","doi-asserted-by":"publisher","first-page":"535","DOI":"10.7326\/0003-4819-158-7-201304020-00005","volume":"158","author":"HA Fink","year":"2013","unstructured":"Fink HA et al (2013) Medical management to prevent recurrent nephrolithiasis in adults: a systematic review for an American college of physicians clinical guideline. Ann Intern Med 158(7):535\u2013543. https:\/\/doi.org\/10.7326\/0003-4819-158-7-201304020-00005","journal-title":"Ann Intern Med"},{"key":"3160_CR124","first-page":"183","volume":"95","author":"LH Smith","year":"1984","unstructured":"Smith LH (1984) P. G. <>Werness Hydroxyapatite\u2013the forgotten crystal in calcium urolithiasis. Trans Am Clin Climatol Assoc 95 183\u2013190 https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/6679136 [Online]. Available:","journal-title":"Trans Am Clin Climatol Assoc"},{"issue":"4","key":"3160_CR125","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/s0022-5347(17)45868-x","volume":"135","author":"SR Khan","year":"1986","unstructured":"Khan SR, Hackett RL (1986) Identification of urinary stone and sediment crystals by scanning electron microscopy and x-ray microanalysis. J Urol 135(4):818\u2013825. https:\/\/doi.org\/10.1016\/s0022-5347(17)45868-x","journal-title":"J Urol"},{"key":"3160_CR126","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/S0022-5347(17)64842-0","volume":"88","author":"LC Herring","year":"1962","unstructured":"Herring LC (1962) Observations on the analysis of ten thousand urinary calculi. J Urol 88:545\u2013562. https:\/\/doi.org\/10.1016\/S0022-5347(17)64842-0","journal-title":"J Urol"},{"issue":"7","key":"3160_CR127","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.2215\/CJN.00560112","volume":"7","author":"DS Goldfarb","year":"2012","unstructured":"Goldfarb DS (2012) A woman with recurrent calcium phosphate kidney stones. Clin J Am Soc Nephrol 7(7):1172\u20131178. https:\/\/doi.org\/10.2215\/CJN.00560112","journal-title":"Clin J Am Soc Nephrol"},{"key":"3160_CR128","unstructured":"Karki N, Leslie SW (2025) Struvite and Triple Phosphate Renal Calculi, in StatPearls. Treasure Island (FL)"},{"issue":"6","key":"3160_CR129","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1097\/00000658-193706000-00014","volume":"105","author":"A Randall","year":"1937","unstructured":"Randall A (1937) The origin and growth of renal calculi. Ann Surg 105(6):1009\u20131027. https:\/\/doi.org\/10.1097\/00000658-193706000-00014","journal-title":"Ann Surg"},{"issue":"4 Pt 2","key":"3160_CR130","doi-asserted-by":"publisher","first-page":"F604","DOI":"10.1152\/ajprenal.1996.270.4.F604","volume":"270","author":"JR Asplin","year":"1996","unstructured":"Asplin JR, Mandel NS, Coe FL (1996) Evidence of calcium phosphate supersaturation in the loop of Henle. Am J Physiol 270(4 Pt 2):F604\u2013F613. https:\/\/doi.org\/10.1152\/ajprenal.1996.270.4.F604","journal-title":"Am J Physiol"},{"issue":"1","key":"3160_CR131","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1046\/j.1523-1755.2001.00477.x","volume":"59","author":"JM Fasano","year":"2001","unstructured":"Fasano JM, Khan SR (2001) Intratubular crystallization of calcium oxalate in the presence of membrane vesicles: an in vitro study. Kidney Int 59(1):169\u2013178. https:\/\/doi.org\/10.1046\/j.1523-1755.2001.00477.x","journal-title":"Kidney Int"},{"key":"3160_CR132","doi-asserted-by":"publisher","first-page":"s326","DOI":"10.2741\/1053","volume":"8","author":"HG Tiselius","year":"2003","unstructured":"Tiselius HG (2003) Is precipitation of calcium phosphate an important factor for the development of calcium oxalate stones in the urinary tract? Front Biosci 8:s326\u2013s332. https:\/\/doi.org\/10.2741\/1053","journal-title":"Front Biosci"},{"issue":"5","key":"3160_CR133","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/j.kint.2024.01.031","volume":"105","author":"Z Zhu","year":"2024","unstructured":"Zhu Z et al (2024) An update on clinical presentation and responses to therapy of patients with hereditary hypophosphatemic rickets with hypercalciuria (HHRH). Kidney Int 105(5):1058\u20131076. https:\/\/doi.org\/10.1016\/j.kint.2024.01.031","journal-title":"Kidney Int"},{"issue":"12","key":"3160_CR134","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1007\/s00467-016-3443-0","volume":"31","author":"D Dinour","year":"2016","unstructured":"Dinour D et al (2016) Loss of function of NaPiIIa causes nephrocalcinosis and possibly kidney insufficiency. Pediatr Nephrol 31(12):2289\u20132297. https:\/\/doi.org\/10.1007\/s00467-016-3443-0","journal-title":"Pediatr Nephrol"},{"issue":"5","key":"3160_CR135","doi-asserted-by":"publisher","first-page":"F1109","DOI":"10.1152\/ajprenal.00620.2007","volume":"294","author":"SR Khan","year":"2008","unstructured":"Khan SR, Glenton PA (2008) Calcium oxalate crystal deposition in kidneys of hypercalciuric mice with disrupted type IIa sodium-phosphate cotransporter. Am J Physiol Ren Physiol 294(5):F1109\u2013F1115. https:\/\/doi.org\/10.1152\/ajprenal.00620.2007","journal-title":"Am J Physiol Ren Physiol"},{"issue":"3","key":"3160_CR136","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/j.juro.2011.04.109","volume":"186","author":"SR Khan","year":"2011","unstructured":"Khan SR, Canales BK (2011) Ultrastructural investigation of crystal deposits in Npt2a knockout mice: are they similar to human Randall\u2019s plaques? J Urol 186(3):1107\u20131113. https:\/\/doi.org\/10.1016\/j.juro.2011.04.109","journal-title":"J Urol"},{"issue":"4","key":"3160_CR137","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/s41581-021-00513-4","volume":"18","author":"P Singh","year":"2022","unstructured":"Singh P, Harris PC, Sas DJ, Lieske JC (2022) The genetics of kidney stone disease and nephrocalcinosis. Nat Rev Nephrol 18(4):224\u2013240. https:\/\/doi.org\/10.1038\/s41581-021-00513-4","journal-title":"Nat Rev Nephrol"},{"issue":"7","key":"3160_CR138","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/s41585-020-0332-x","volume":"17","author":"SA Howles","year":"2020","unstructured":"Howles SA, Thakker RV (2020) Genetics of kidney stone disease. Nat Rev Urol 17(7):407\u2013421. https:\/\/doi.org\/10.1038\/s41585-020-0332-x","journal-title":"Nat Rev Urol"},{"issue":"5","key":"3160_CR139","doi-asserted-by":"publisher","first-page":"943","DOI":"10.2215\/CJN.08210813","volume":"9","author":"JC Lieske","year":"2014","unstructured":"Lieske JC, Turner ST, Edeh SN, Smith JA, Kardia SL (2014) Heritability of urinary traits that contribute to nephrolithiasis. Clin J Am Soc Nephrol 9(5):943\u2013950. https:\/\/doi.org\/10.2215\/CJN.08210813","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"3160_CR140","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s00345-022-04221-x","volume":"41","author":"R Unno","year":"2023","unstructured":"Unno R et al (2023) Maternal family history of urolithiasis is associated with earlier age of onset of stone disease. World J Urol 41(1):241\u2013247. https:\/\/doi.org\/10.1007\/s00345-022-04221-x","journal-title":"World J Urol"},{"issue":"3","key":"3160_CR141","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1681\/ASN.2014040388","volume":"26","author":"J Halbritter","year":"2015","unstructured":"Halbritter J et al (2015) Fourteen monogenic genes account for 15% of nephrolithiasis\/nephrocalcinosis. J Am Soc Nephrol 26(3):543\u2013551. https:\/\/doi.org\/10.1681\/ASN.2014040388","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"3160_CR142","doi-asserted-by":"publisher","first-page":"2862","DOI":"10.1016\/j.ekir.2021.08.033","volume":"6","author":"AG Cogal","year":"2021","unstructured":"Cogal AG et al (2021) Comprehensive genetic analysis reveals complexity of monogenic urinary stone disease. Kidney Int Rep 6(11):2862\u20132884. https:\/\/doi.org\/10.1016\/j.ekir.2021.08.033","journal-title":"Kidney Int Rep"},{"issue":"8","key":"3160_CR143","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1007\/s00467-023-05879-0","volume":"38","author":"AM Gefen","year":"2023","unstructured":"Gefen AM et al (2023) Genetic testing in children with nephrolithiasis and nephrocalcinosis. Pediatr Nephrol 38(8):2615\u20132622. https:\/\/doi.org\/10.1007\/s00467-023-05879-0","journal-title":"Pediatr Nephrol"},{"key":"3160_CR144","doi-asserted-by":"publisher","unstructured":"Lovegrove CE et al (2025) Genetic variants predisposing to increased risk of kidney stone disease. J Clin Invest May 15. https:\/\/doi.org\/10.1172\/JCI186915","DOI":"10.1172\/JCI186915"},{"issue":"1","key":"3160_CR145","doi-asserted-by":"publisher","first-page":"3473","DOI":"10.1038\/s41467-025-58782-7","volume":"16","author":"X Cao","year":"2025","unstructured":"Cao X et al (2025) Trans-ancestry GWAS identifies 59 loci and improves risk prediction and fine-mapping for kidney stone disease. Nat Commun 16(1):3473. https:\/\/doi.org\/10.1038\/s41467-025-58782-7","journal-title":"Nat Commun"},{"key":"3160_CR146","doi-asserted-by":"publisher","unstructured":"Li S, Wang X, Liu M (2025) Genetic susceptibility to kidney stone disease: unveiling pathogenesis and potential therapeutic targets. J Clin Invest 135(15). https:\/\/doi.org\/10.1172\/JCI195624","DOI":"10.1172\/JCI195624"},{"key":"3160_CR147","doi-asserted-by":"publisher","unstructured":"Cogal AG et al (2025) Genetic and Clinical Characterization of a Large Cohort with Suspected Monogenic Stone Disease. Clin J Am Soc Nephrol. https:\/\/doi.org\/10.2215\/CJN.0000000817","DOI":"10.2215\/CJN.0000000817"},{"issue":"1","key":"3160_CR148","doi-asserted-by":"publisher","first-page":"5175","DOI":"10.1038\/s41467-019-13145-x","volume":"10","author":"SA Howles","year":"2019","unstructured":"Howles SA et al (2019) Genetic variants of calcium and vitamin D metabolism in kidney stone disease. Nat Commun 10(1):5175. https:\/\/doi.org\/10.1038\/s41467-019-13145-x","journal-title":"Nat Commun"},{"issue":"7899","key":"3160_CR149","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41586-022-04394-w","volume":"603","author":"BB Sun","year":"2022","unstructured":"Sun BB et al (2022) Genetic associations of protein-coding variants in human disease. Nature 603(7899):95\u2013102. https:\/\/doi.org\/10.1038\/s41586-022-04394-w","journal-title":"Nature"},{"issue":"13","key":"3160_CR150","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1056\/NEJMoa020028","volume":"347","author":"D Prie","year":"2002","unstructured":"Prie D et al (2002) Nephrolithiasis and osteoporosis associated with hypophosphatemia caused by mutations in the type 2a sodium-phosphate cotransporter. N Engl J Med 347(13):983\u2013991. https:\/\/doi.org\/10.1056\/NEJMoa020028","journal-title":"N Engl J Med"},{"issue":"12","key":"3160_CR151","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1038\/sj.ki.5000437","volume":"69","author":"JY Lapointe","year":"2006","unstructured":"Lapointe JY et al (2006) NPT2a gene variation in calcium nephrolithiasis with renal phosphate leak. Kidney Int 69(12):2261\u20132267. https:\/\/doi.org\/10.1038\/sj.ki.5000437","journal-title":"Kidney Int"},{"key":"3160_CR152","doi-asserted-by":"publisher","first-page":"S88","DOI":"10.1016\/j.nephro.2020.02.003","volume":"17S","author":"J Halbritter","year":"2021","unstructured":"Halbritter J (2021) Genetics of kidney stone disease-Polygenic meets monogenic. Nephrol Ther 17S:S88\u2013S94. https:\/\/doi.org\/10.1016\/j.nephro.2020.02.003","journal-title":"Nephrol Ther"},{"issue":"5","key":"3160_CR153","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.kint.2023.06.019","volume":"104","author":"O Sadeghi-Alavijeh","year":"2023","unstructured":"Sadeghi-Alavijeh O et al (2023) Rare variants in the sodium-dependent phosphate transporter gene SLC34A3 explain missing heritability of urinary stone disease. Kidney Int 104(5):975\u2013984. https:\/\/doi.org\/10.1016\/j.kint.2023.06.019","journal-title":"Kidney Int"},{"issue":"9","key":"3160_CR154","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1001\/jamasurg.2020.2423","volume":"155","author":"C Ganesan","year":"2020","unstructured":"Ganesan C et al (2020) Analysis of primary hyperparathyroidism screening among US veterans with kidney stones. JAMA Surg 155(9):861\u2013868. https:\/\/doi.org\/10.1001\/jamasurg.2020.2423","journal-title":"JAMA Surg"},{"issue":"1","key":"3160_CR155","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/s0002-9343(03)00201-8","volume":"115","author":"CY Pak","year":"2003","unstructured":"Pak CY, Poindexter JR, Adams-Huet B, Pearle MS (2003) Predictive value of kidney stone composition in the detection of metabolic abnormalities. Am J Med 115(1):26\u201332. https:\/\/doi.org\/10.1016\/s0002-9343(03)00201-8","journal-title":"Am J Med"},{"issue":"3","key":"3160_CR156","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s00240-020-01226-2","volume":"49","author":"P Lanka","year":"2021","unstructured":"Lanka P, Devana SK, Singh SK, Sapehia D, Kaur J (2021) Klotho gene polymorphism in renal stone formers from Northwestern India. Urolithiasis 49(3):195\u2013199. https:\/\/doi.org\/10.1007\/s00240-020-01226-2","journal-title":"Urolithiasis"},{"key":"3160_CR157","doi-asserted-by":"publisher","first-page":"913908","DOI":"10.3389\/fgene.2022.913908","volume":"13","author":"A Mohammadi","year":"2022","unstructured":"Mohammadi A et al (2022) Genetic Polymorphisms and Kidney Stones Around the Globe: A Systematic Review and Meta-Analysis. Front Genet 13:913908. https:\/\/doi.org\/10.3389\/fgene.2022.913908","journal-title":"Front Genet"},{"issue":"3","key":"3160_CR158","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1210\/jc.2005-1606","volume":"91","author":"D De Rendina","year":"2006","unstructured":"Rendina D, Mossetti G, De Filippo G, Cioffi M, Strazzullo P (2006) Fibroblast growth factor 23 is increased in calcium nephrolithiasis with hypophosphatemia and renal phosphate leak. J Clin Endocrinol Metab 91(3):959\u2013963. https:\/\/doi.org\/10.1210\/jc.2005-1606","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"3160_CR159","doi-asserted-by":"publisher","first-page":"E840","DOI":"10.1210\/jc.2011-1528","volume":"97","author":"D Rendina","year":"2012","unstructured":"Rendina D et al (2012) A functional allelic variant of the FGF23 gene is associated with renal phosphate leak in calcium nephrolithiasis. J Clin Endocrinol Metab 97(5):E840\u2013E844. https:\/\/doi.org\/10.1210\/jc.2011-1528","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"3160_CR160","doi-asserted-by":"publisher","first-page":"667","DOI":"10.2215\/CJN.07060714","volume":"10","author":"EN Taylor","year":"2015","unstructured":"Taylor EN, Hoofnagle AN, Curhan GC (2015) Calcium and phosphorus regulatory hormones and risk of incident symptomatic kidney stones. Clin J Am Soc Nephrol 10(4):667\u2013675. https:\/\/doi.org\/10.2215\/CJN.07060714","journal-title":"Clin J Am Soc Nephrol"},{"key":"3160_CR161","doi-asserted-by":"publisher","unstructured":"Jayachandran M et al (2020) Specific populations of urinary extracellular vesicles and proteins differentiate type 1 primary hyperoxaluria patients without and with nephrocalcinosis or kidney stones. Orphanet J Rare Dis 15(1):319. https:\/\/doi.org\/10.1186\/s13023-020-01607-1","DOI":"10.1186\/s13023-020-01607-1"},{"key":"3160_CR162","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1159\/000531045","volume":"54","author":"Y Xiao","year":"2023","unstructured":"Xiao Y, Xiao Z (2023) Association between Serum Klotho and Kidney Stones in US Middle-Aged and Older Individuals with Diabetes Mellitus: Results from 2007 to 2016 National Health and Nutrition Survey. Am J Nephrol 54:5\u20136. https:\/\/doi.org\/10.1159\/000531045","journal-title":"Am J Nephrol"},{"issue":"1","key":"3160_CR163","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s00240-025-01836-8","volume":"53","author":"L Chen","year":"2025","unstructured":"Chen L, Xie L, Wu B, Zhao W (2025) Assessing causal associations of FGF23 and alpha-Klotho with urolithiasis using Mendelian randomization analysis. Urolithiasis 53(1):161. https:\/\/doi.org\/10.1007\/s00240-025-01836-8","journal-title":"Urolithiasis"},{"issue":"3","key":"3160_CR164","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/embj.201284188","volume":"33","author":"O Andrukhova","year":"2014","unstructured":"Andrukhova O et al (2014) FGF23 promotes renal calcium reabsorption through the TRPV5 channel. EMBO J 33(3):229\u2013246. https:\/\/doi.org\/10.1002\/embj.201284188","journal-title":"EMBO J"},{"issue":"12","key":"3160_CR165","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1089\/end.2013.0173","volume":"27","author":"JM Riley","year":"2013","unstructured":"Riley JM, Kim H, Averch TD, Kim HJ (2013) Effect of magnesium on calcium and oxalate ion binding. J Endourol 27(12):1487\u20131492. https:\/\/doi.org\/10.1089\/end.2013.0173","journal-title":"J Endourol"},{"issue":"9","key":"3160_CR166","doi-asserted-by":"publisher","first-page":"sfaf244","DOI":"10.1093\/ckj\/sfaf244","volume":"18","author":"A Zomorodian","year":"2025","unstructured":"Zomorodian A, Moe OW (2025) Citrate and calcium kidney stones. Clin Kidney J 18(9):sfaf244. https:\/\/doi.org\/10.1093\/ckj\/sfaf244","journal-title":"Clin Kidney J"},{"key":"3160_CR167","doi-asserted-by":"crossref","unstructured":"Wagner CA, Mohebbi N Urinary pH and stone formation. J Nephrol 23(Suppl 16):S165\u20139. [Online]. Available: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21170875","DOI":"10.1093\/joneph\/23.S16.S165"},{"issue":"9","key":"3160_CR168","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1007\/s00345-021-03680-y","volume":"39","author":"S Zhang","year":"2021","unstructured":"Zhang S et al (2021) Trends in urinary stone composition in 23,182 stone analyses from 2011 to 2019: a high-volume center study in China. World J Urol 39(9):3599\u20133605. https:\/\/doi.org\/10.1007\/s00345-021-03680-y","journal-title":"World J Urol"},{"issue":"3","key":"3160_CR169","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.ekir.2023.12.020","volume":"9","author":"AA Yau","year":"2024","unstructured":"Yau AA (2024) The conundrum of alkali therapy in calcium phosphate stone formers. Kidney Int Rep 9(3):721\u2013724. https:\/\/doi.org\/10.1016\/j.ekir.2023.12.020","journal-title":"Kidney Int Rep"},{"issue":"1","key":"3160_CR170","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/s0022-5347(17)37202-6","volume":"147","author":"SR Khan","year":"1992","unstructured":"Khan SR, Shevock PN, Hackett RL (Jan 1992) Acute hyperoxaluria, renal injury and calcium oxalate urolithiasis. J Urol 147(1):226\u2013230. https:\/\/doi.org\/10.1016\/s0022-5347(17)37202-6","journal-title":"J Urol"},{"issue":"2","key":"3160_CR171","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/ki.1996.60","volume":"49","author":"C Scheid","year":"1996","unstructured":"Scheid C et al (1996) Oxalate toxicity in LLC-PK1 cells: role of free radicals. Kidney Int 49(2):413\u2013419. https:\/\/doi.org\/10.1038\/ki.1996.60","journal-title":"Kidney Int"},{"key":"3160_CR172","unstructured":"Wiessner JH, Hasegawa AT, Hung LY, Mandel NS Oxalate-induced exposure of phosphatidylserine on the surface of renal epithelial cells in culture. J Am Soc Nephrol 10(Suppl 14):S441\u20135. [Online]. Available: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10541280"},{"key":"3160_CR173","doi-asserted-by":"publisher","first-page":"10274","DOI":"10.1038\/ncomms10274","volume":"7","author":"SR Mulay","year":"2016","unstructured":"Mulay SR et al (2016) Cytotoxicity of crystals involves RIPK3-MLKL-mediated necroptosis. Nat Commun 7:10274. https:\/\/doi.org\/10.1038\/ncomms10274","journal-title":"Nat Commun"},{"issue":"1","key":"3160_CR174","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1172\/JCI63679","volume":"123","author":"SR Mulay","year":"2013","unstructured":"Mulay SR et al (2013) Calcium oxalate crystals induce renal inflammation by NLRP3-mediated IL-1beta secretion. J Clin Invest 123(1):236\u2013246. https:\/\/doi.org\/10.1172\/JCI63679","journal-title":"J Clin Invest"},{"key":"3160_CR175","doi-asserted-by":"publisher","first-page":"617508","DOI":"10.3389\/fimmu.2021.617508","volume":"12","author":"P Kumar","year":"2021","unstructured":"Kumar P et al (2021) Dietary Oxalate Loading Impacts Monocyte Metabolism and Inflammatory Signaling in Humans. Front Immunol 12:617508. https:\/\/doi.org\/10.3389\/fimmu.2021.617508","journal-title":"Front Immunol"},{"key":"3160_CR176","doi-asserted-by":"publisher","first-page":"102919","DOI":"10.1016\/j.redox.2023.102919","volume":"67","author":"P Kumar","year":"2023","unstructured":"Kumar P, Laurence E, Crossman DK, Assimos DG, Murphy MP, Mitchell T (2023) Oxalate disrupts monocyte and macrophage cellular function via Interleukin-10 and mitochondrial reactive oxygen species (ROS) signaling. Redox Biol 67:102919. https:\/\/doi.org\/10.1016\/j.redox.2023.102919","journal-title":"Redox Biol"},{"issue":"4","key":"3160_CR177","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1046\/j.1523-1755.2003.00226.x","volume":"64","author":"K Aihara","year":"2003","unstructured":"Aihara K, Byer KJ, Khan SR (2003) Calcium phosphate-induced renal epithelial injury and stone formation: involvement of reactive oxygen species. Kidney Int 64(4):1283\u20131291. https:\/\/doi.org\/10.1046\/j.1523-1755.2003.00226.x","journal-title":"Kidney Int"},{"issue":"2","key":"3160_CR178","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1159\/000487671","volume":"4","author":"SR Mulay","year":"2018","unstructured":"Mulay SR, Shi C, Ma X, Anders HJ (2018) Novel Insights into Crystal-Induced Kidney Injury. Kidney Dis (Basel) 4(2):49\u201357. https:\/\/doi.org\/10.1159\/000487671","journal-title":"Kidney Dis (Basel)"},{"issue":"7","key":"3160_CR179","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/j.mayocp.2024.02.006","volume":"99","author":"G Hawkins-van der","year":"2024","unstructured":"Hawkins-van der G, Cingel SB, Walsh KU, Eckardt, Knauf F (2024) Oxalate metabolism: From kidney stones to cardiovascular disease. Mayo Clin Proc 99(7):1149\u20131161. https:\/\/doi.org\/10.1016\/j.mayocp.2024.02.006","journal-title":"Mayo Clin Proc"},{"issue":"8","key":"3160_CR180","doi-asserted-by":"publisher","first-page":"F785","DOI":"10.1152\/ajprenal.00488.2015","volume":"310","author":"SR Mulay","year":"2016","unstructured":"Mulay SR et al (2016) Oxalate-induced chronic kidney disease with its uremic and cardiovascular complications in C57BL\/6 mice. Am J Physiol Ren Physiol 310(8):F785\u2013F795. https:\/\/doi.org\/10.1152\/ajprenal.00488.2015","journal-title":"Am J Physiol Ren Physiol"},{"issue":"5","key":"3160_CR181","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.kint.2023.08.021","volume":"104","author":"J Halbritter","year":"2023","unstructured":"Halbritter J (2023) Urinary stone disease: closing the heritability gap by challenging conventional Mendelian inheritance. Kidney Int 104(5):882\u2013885. https:\/\/doi.org\/10.1016\/j.kint.2023.08.021","journal-title":"Kidney Int"},{"issue":"3","key":"3160_CR182","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1159\/000185055","volume":"49","author":"G Barsotti","year":"1988","unstructured":"Barsotti G et al (1988) Protection of renal function and of nutritional status in uremic rats by means of a low-protein, low-phosphorus supplemented diet. Nephron 49(3):197\u2013202. https:\/\/doi.org\/10.1159\/000185055","journal-title":"Nephron"},{"key":"3160_CR183","doi-asserted-by":"crossref","unstructured":"Koizumi T, Murakami K, Nakayama H, Kuwahara T, Yoshinari O (2002) Role of dietary phosphorus in the progression of renal failure, (in eng). Biochem Biophys Res Commun 295(4):917\u2013921. doi: S0006291X02007933 [pii].","DOI":"10.1016\/S0006-291X(02)00793-3"},{"issue":"5","key":"3160_CR184","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/ki.1983.197","volume":"24","author":"S Klahr","year":"1983","unstructured":"Klahr S, Buerkert J, Purkerson ML (1983) Role of dietary factors in the progression of chronic renal disease. Kidney Int 24(5):579\u2013587. https:\/\/doi.org\/10.1038\/ki.1983.197","journal-title":"Kidney Int"},{"issue":"6","key":"3160_CR185","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1042\/cs0630539","volume":"63","author":"D Laouari","year":"1982","unstructured":"Laouari D, Kleinknecht C, Cournot-Witmer G, Habib R, Mounier F, Broyer M (1982) Beneficial effect of low phosphorus diet in uraemic rats: a reappraisal. Clin Sci (Lond) 63(6):539\u2013548. https:\/\/doi.org\/10.1042\/cs0630539","journal-title":"Clin Sci (Lond)"},{"issue":"3","key":"3160_CR186","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1038\/ki.1986.49","volume":"29","author":"D Lumlertgul","year":"1986","unstructured":"Lumlertgul D et al (1986) Phosphate depletion arrests progression of chronic renal failure independent of protein intake. Kidney Int 29(3):658\u2013666. https:\/\/doi.org\/10.1038\/ki.1986.49","journal-title":"Kidney Int"},{"issue":"6","key":"3160_CR187","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/s0272-6386(88)80085-4","volume":"11","author":"DC Harris","year":"1988","unstructured":"Harris DC, Falk SA, Conger JD, Hammond WS, Schrier RW (Jun 1988) Phosphate restriction reduces proteinuria of the uninephrectomized, diabetic rat. Am J Kidney Dis 11(6):489\u2013498. https:\/\/doi.org\/10.1016\/s0272-6386(88)80085-4","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"3160_CR188","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1038\/s41598-018-38389-3","volume":"9","author":"Y Nemoto","year":"2019","unstructured":"Nemoto Y et al (2019) Phosphate binding by sucroferric oxyhydroxide ameliorates renal injury in the remnant kidney model. Sci Rep 9(1):1732. https:\/\/doi.org\/10.1038\/s41598-018-38389-3","journal-title":"Sci Rep"},{"issue":"5","key":"3160_CR189","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1681\/ASN.2014030317","volume":"26","author":"ED Labonte","year":"2015","unstructured":"Labonte ED et al (2015) Gastrointestinal Inhibition of Sodium-Hydrogen Exchanger 3 Reduces Phosphorus Absorption and Protects against Vascular Calcification in CKD. J Am Soc Nephrol 26(5):1138\u20131149. https:\/\/doi.org\/10.1681\/ASN.2014030317","journal-title":"J Am Soc Nephrol"},{"key":"3160_CR190","doi-asserted-by":"crossref","unstructured":"Karlinsky ML, Haut L, Buddington B, Schrier NA, Alfrey AC (1980) Preservation of renal function in experimental glomerulonephritis. Kidney Int 17(3):293\u2013302. [Online]. Available: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7401449","DOI":"10.1038\/ki.1980.35"},{"issue":"3","key":"3160_CR191","doi-asserted-by":"publisher","first-page":"237","DOI":"10.3177\/jnsv.54.237","volume":"54","author":"K Kusano","year":"2008","unstructured":"Kusano K, Segawa H, Ohnishi R, Fukushima N, Miyamoto K (2008) Role of low protein and low phosphorus diet in the progression of chronic kidney disease in uremic rats. J Nutr Sci Vitaminol (Tokyo) 54(3):237\u2013243. https:\/\/doi.org\/10.3177\/jnsv.54.237","journal-title":"J Nutr Sci Vitaminol (Tokyo)"},{"issue":"2","key":"3160_CR192","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.kint.2020.02.040","volume":"98","author":"Y Tsuboi","year":"2020","unstructured":"Tsuboi Y et al (2020) EOS789, a novel pan-phosphate transporter inhibitor, is effective for the treatment of chronic kidney disease-mineral bone disorder. Kidney Int 98(2):343\u2013354. https:\/\/doi.org\/10.1016\/j.kint.2020.02.040","journal-title":"Kidney Int"},{"issue":"1","key":"3160_CR193","doi-asserted-by":"publisher","first-page":"F35","DOI":"10.1152\/ajprenal.00282.2019","volume":"318","author":"F Omede","year":"2020","unstructured":"Omede F et al (2020) Dietary phosphate restriction attenuates polycystic kidney disease in mice. Am J Physiol Ren Physiol 318(1):F35\u2013F42. https:\/\/doi.org\/10.1152\/ajprenal.00282.2019","journal-title":"Am J Physiol Ren Physiol"},{"key":"3160_CR194","doi-asserted-by":"crossref","unstructured":"Ross LA, Finco DR, Crowell WA (1982) Effect of dietary phosphorus restriction on the kidneys of cats with reduced renal mass, (in eng). Am J Vet Res 43(6):1023\u20136. [Online]. Available: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7103172","DOI":"10.2460\/ajvr.1982.43.06.1023"},{"key":"3160_CR195","doi-asserted-by":"crossref","unstructured":"Lund EM, Armstrong PJ, Kirk CA, Kolar LM, Klausner JS (1999) Health status and population characteristics of dogs and cats examined at private veterinary practices in the United States, (in eng). J Am Vet Med Assoc 214(9):1336\u201341. [Online]. Available: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10319174","DOI":"10.2460\/javma.1999.214.09.1336"},{"issue":"2","key":"3160_CR196","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1177\/1098612X14536176","volume":"17","author":"DG O\u2019Neill","year":"2015","unstructured":"O\u2019Neill DG, Church DB, McGreevy PD, Thomson PC, Brodbelt DC (2015) Longevity and mortality of cats attending primary care veterinary practices in England. J Feline Med Surg 17(2):125\u2013133. https:\/\/doi.org\/10.1177\/1098612X14536176","journal-title":"J Feline Med Surg"},{"key":"3160_CR197","doi-asserted-by":"publisher","first-page":"105842","DOI":"10.1016\/j.tvjl.2022.105842","volume":"283\u2013284","author":"J Elliott","year":"2022","unstructured":"Elliott J, Geddes RF (2022) New concepts in phosphorus homeostasis and its impact on renal health with particular reference to the cat. Vet J 283\u2013284:105842. https:\/\/doi.org\/10.1016\/j.tvjl.2022.105842","journal-title":"Vet J"},{"key":"3160_CR198","first-page":"120","volume":"4","author":"VM Lucke","year":"1967","unstructured":"Lucke VM, Hunt AC (1967) Renal calcification in the domestic cat. Path Vet 4:120\u2013136","journal-title":"Path Vet"},{"key":"3160_CR199","doi-asserted-by":"crossref","unstructured":"Pastoor FJ, Opitz R, A. T. Van \u2018t Klooster, and, Beynen AC (1995) Dietary phosphorus restriction to half the minimum required amount slightly reduces weight gain and length of tibia, but sustains femur mineralization and prevents nephrocalcinosis in female kittens, (in eng). Br J Nutr 74(1):85\u2013100. doi: S0007114595001103 [pii]","DOI":"10.1079\/BJN19950109"},{"issue":"10","key":"3160_CR200","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1681\/ASN.2011121213","volume":"23","author":"SC Schiavi","year":"2012","unstructured":"Schiavi SC et al (2012) Npt2b deletion attenuates hyperphosphatemia associated with CKD. J Am Soc Nephrol 23(10):1691\u20131700. https:\/\/doi.org\/10.1681\/ASN.2011121213","journal-title":"J Am Soc Nephrol"},{"key":"3160_CR201","doi-asserted-by":"publisher","first-page":"965","DOI":"10.2215\/CJN.10941016","volume":"12","author":"R Wald","year":"2017","unstructured":"Wald R et al (2017) Two phosphAte taRGets in End-stage renal disease Trial (TARGET): A Randomized Controlled Trial. Clin J Am Soc Nephrol 12:965\u2013973. https:\/\/doi.org\/10.2215\/CJN.10941016","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"3160_CR202","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12882-019-1216-2","volume":"20","author":"R Bhargava","year":"2019","unstructured":"Bhargava R, Kalra PA, Hann M, Brenchley P, Hurst H, Hutchison AJ (2019) A randomized controlled trial of different serum phosphate ranges in subjects on hemodialysis. BMC Nephrol 20(1):37. https:\/\/doi.org\/10.1186\/s12882-019-1216-2","journal-title":"BMC Nephrol"},{"issue":"1","key":"3160_CR203","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1097\/MNH.0000000000000460","volume":"28","author":"R Wald","year":"2019","unstructured":"Wald R, Thorpe KE, Walsh MW (2019) Leveraging pragmatic clinical trial design to advance phosphate management in end-stage renal disease. Curr Opin Nephrol Hypertens 28(1):34\u201339. https:\/\/doi.org\/10.1097\/MNH.0000000000000460","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"6","key":"3160_CR204","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1053\/j.ajkd.2020.10.008","volume":"77","author":"DL Edmonston","year":"2021","unstructured":"Edmonston DL et al (2021) Design and rationale of HiLo: A pragmatic, randomized trial of phosphate management for patients receiving maintenance hemodialysis. Am J Kidney Dis 77(6):920\u2013930. https:\/\/doi.org\/10.1053\/j.ajkd.2020.10.008","journal-title":"Am J Kidney Dis"},{"key":"3160_CR205","unstructured":"Barsotti G et al (1984) The decline of renal function slowed by very low phosphorus intake in chronic renal patients following a low nitrogen diet. Clin Nephrol 21(1):54\u201359. [Online]. Available: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/6705274"},{"key":"3160_CR206","unstructured":"Maschio G et al (1983) Early dietary protein and phosphorus restriction is effective in delaying progression of chronic renal failure. Kidney Int Suppl 16:S273\u20137. [Online]. Available: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/6588264"},{"key":"3160_CR207","doi-asserted-by":"crossref","unstructured":"Maschio G et al (1982) Effects of dietary protein and phosphorus restriction on the progression of early renal failure. Kidney Int 22(4);371\u20136. [Online]. Available: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7176336","DOI":"10.1038\/ki.1982.184"},{"key":"3160_CR208","unstructured":"Barsotti G, Morelli E, Giannoni A, Guiducci A, Lupetti S, Giovannetti S (1983) Restricted phosphorus and nitrogen intake to slow the progression of chronic renal failure: a controlled trial. Kidney Int Suppl 16:S278\u201384. [Online]. Available: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/6376918"},{"issue":"2","key":"3160_CR209","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1056\/NEJM199101103240202","volume":"324","author":"K Zeller","year":"1991","unstructured":"Zeller K, Whittaker E, Sullivan L, Raskin P, Jacobson HR (1991) Effect of restricting dietary protein on the progression of renal failure in patients with insulin-dependent diabetes mellitus. N Engl J Med 324(2):78\u201384. https:\/\/doi.org\/10.1056\/NEJM199101103240202","journal-title":"N Engl J Med"},{"key":"3160_CR210","unstructured":"Williams PS, Stevens ME, Fass G, Irons L, Bone JM (1991) Failure of dietary protein and phosphate restriction to retard the rate of progression of chronic renal failure: a prospective, randomized, controlled trial. Q J Med 81(294):837\u201355. [Online]. Available: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1801057"},{"issue":"6","key":"3160_CR211","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1681\/ASN.2018101058","volume":"30","author":"JH Ix","year":"2019","unstructured":"Ix JH et al (2019) Effects of Nicotinamide and Lanthanum Carbonate on Serum Phosphate and Fibroblast Growth Factor-23 in CKD: The COMBINE Trial. J Am Soc Nephrol 30(6):1096\u20131108. https:\/\/doi.org\/10.1681\/ASN.2018101058","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"3160_CR212","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.1681\/ASN.2020040411","volume":"31","author":"ND Toussaint","year":"2020","unstructured":"Toussaint ND et al (2020) A randomized trial on the effect of phosphate reduction on vascular end points in CKD (IMPROVE-CKD). J Am Soc Nephrol 31(11):2653\u20132666. https:\/\/doi.org\/10.1681\/ASN.2020040411","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"3160_CR213","doi-asserted-by":"publisher","first-page":"CD006023","DOI":"10.1002\/14651858.CD006023.pub3","volume":"8","author":"M Ruospo","year":"2018","unstructured":"Ruospo M et al (2018) Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD). Cochrane Database Syst Rev 8(8):CD006023. https:\/\/doi.org\/10.1002\/14651858.CD006023.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"3160_CR214","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.1161\/CIRCULATIONAHA.105.553198","volume":"112","author":"M Tonelli","year":"2005","unstructured":"Tonelli M et al (2005) Relation between serum phosphate level and cardiovascular event rate in people with coronary disease. Circulation 112, no. 17:2627\u201333. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.105.553198","journal-title":"Circulation"},{"issue":"7","key":"3160_CR215","doi-asserted-by":"publisher","first-page":"e102276","DOI":"10.1371\/journal.pone.0102276","volume":"9","author":"JW Li","year":"2014","unstructured":"Li JW, Xu C, Fan Y, Wang Y, Xiao YB (2014) Can serum levels of alkaline phosphatase and phosphate predict cardiovascular diseases and total mortality in individuals with preserved renal function? A systemic review and meta-analysis. PLoS ONE 9(7):e102276. https:\/\/doi.org\/10.1371\/journal.pone.0102276","journal-title":"PLoS ONE"},{"issue":"6","key":"3160_CR216","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.2215\/CJN.01660309","volume":"4","author":"RN Foley","year":"2009","unstructured":"Foley RN (2009) Phosphate levels and cardiovascular disease in the general population. Clin J Am Soc Nephrol 4(6):1136\u20131139. https:\/\/doi.org\/10.2215\/CJN.01660309","journal-title":"Clin J Am Soc Nephrol"},{"issue":"9","key":"3160_CR217","doi-asserted-by":"publisher","first-page":"2885","DOI":"10.1093\/ndt\/gfq808","volume":"26","author":"CM O\u2019Seaghdha","year":"2011","unstructured":"O\u2019Seaghdha CM, Hwang SJ, Muntner P, Melamed ML, Fox CS (2011) Serum phosphorus predicts incident chronic kidney disease and end-stage renal disease. Nephrol Dial Transpl 26(9):2885\u20132890. https:\/\/doi.org\/10.1093\/ndt\/gfq808","journal-title":"Nephrol Dial Transpl"},{"issue":"4","key":"3160_CR218","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.amjmed.2012.08.018","volume":"126","author":"JJ Sim","year":"2013","unstructured":"Sim JJ et al (2013) Phosphorus and risk of renal failure in subjects with normal renal function. Am J Med 126(4):311\u2013318. https:\/\/doi.org\/10.1016\/j.amjmed.2012.08.018","journal-title":"Am J Med"},{"key":"3160_CR219","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1084\/jem.61.3.319","volume":"61","author":"EM Mackay","year":"1935","unstructured":"Mackay EM, Oliver J (1935) Renal damage following the ingestion of a diet containing an excess of inorganic phosphate. J Exp Med 61:319\u2013334. https:\/\/doi.org\/10.1084\/jem.61.3.319","journal-title":"J Exp Med"},{"issue":"2","key":"3160_CR220","doi-asserted-by":"publisher","first-page":"e0150093","DOI":"10.1371\/journal.pone.0150093","volume":"11","author":"ZJ Shen","year":"2016","unstructured":"Shen ZJ, Hu J, Shiizaki K, Kuro-o M, Malter JS (2016) Phosphate-Induced Renal Fibrosis Requires the Prolyl Isomerase Pin1. PLoS ONE 11(2):e0150093. https:\/\/doi.org\/10.1371\/journal.pone.0150093","journal-title":"PLoS ONE"},{"key":"3160_CR221","doi-asserted-by":"publisher","first-page":"173","DOI":"10.2152\/jmi.69.173","volume":"69","author":"S Sasaki","year":"2022","unstructured":"Sasaki S et al (2022) Dietary polyphosphate has a greater effect on renal damage and FGF23 secretion than dietary monophosphate. J Med Invest 69:173\u2013179 3.4. https:\/\/doi.org\/10.2152\/jmi.69.173","journal-title":"J Med Invest"},{"key":"3160_CR222","doi-asserted-by":"publisher","first-page":"627","DOI":"10.3177\/jnsv.43.627","volume":"43","author":"H Matsuzaki","year":"1997","unstructured":"Matsuzaki H et al (1997) High phosphorus diet rapidly induces nephrocalcinosis and proximal tubular injury in rats. J Nutr Sci Vitaminol (Tokyo) 43:627\u2013641. https:\/\/doi.org\/10.3177\/jnsv.43.627","journal-title":"J Nutr Sci Vitaminol (Tokyo)"},{"issue":"5","key":"3160_CR223","doi-asserted-by":"publisher","first-page":"595","DOI":"10.3177\/jnsv.45.595","volume":"45","author":"H Matsuzaki","year":"1999","unstructured":"Matsuzaki H et al (1999) Comparison of various phosphate salts as the dietary phosphorus source on nephrocalcinosis and kidney function in rats. J Nutr Sci Vitaminol (Tokyo) 45(5):595\u2013608. https:\/\/doi.org\/10.3177\/jnsv.45.595","journal-title":"J Nutr Sci Vitaminol (Tokyo)"},{"issue":"4","key":"3160_CR224","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1271\/bbb.65.928","volume":"65","author":"H Matsuzaki","year":"2001","unstructured":"Matsuzaki H, Masuyama R, Uehara M, Nakamura K, Suzuki K (2001) Greater effect of dietary potassium tripolyphosphate than of potassium dihydrogenphosphate on the nephrocalcinosis and proximal tubular function in female rats from the intake of a high-phosphorus diet. Biosci Biotechnol Biochem 65(4):928\u2013934. https:\/\/doi.org\/10.1271\/bbb.65.928","journal-title":"Biosci Biotechnol Biochem"},{"issue":"3","key":"3160_CR225","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3164\/jcbn.2007025","volume":"41","author":"H Matsuzaki","year":"2007","unstructured":"Matsuzaki H, Katsumata S, Uehara M, Suzuki K, Miwa M (2007) High-phosphorus diet induces osteopontin expression of renal tubules in rats. J Clin Biochem Nutr 41(3):179\u2013183. https:\/\/doi.org\/10.3164\/jcbn.2007025","journal-title":"J Clin Biochem Nutr"},{"issue":"4","key":"3160_CR226","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1177\/1098612X17710589","volume":"20","author":"B Dobenecker","year":"2018","unstructured":"Dobenecker B, Webel A, Reese S, Kienzle E (2018) Effect of a high phosphorus diet on indicators of renal health in cats, (in eng). J Feline Med Surg 20(4):339\u2013343. https:\/\/doi.org\/10.1177\/1098612X17710589","journal-title":"J Feline Med Surg"},{"issue":"3","key":"3160_CR227","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1017\/S0007114518002751","volume":"121","author":"J Alexander","year":"2019","unstructured":"Alexander J et al (2019) Effects of the long-term feeding of diets enriched with inorganic phosphorus on the adult feline kidney and phosphorus metabolism. Br J Nutr 121(3):249\u2013269. https:\/\/doi.org\/10.1017\/S0007114518002751","journal-title":"Br J Nutr"},{"issue":"3","key":"3160_CR228","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1017\/S0007114518003379","volume":"121","author":"JC Coltherd","year":"2019","unstructured":"Coltherd JC et al (2019) Not all forms of dietary phosphorus are equal: an evaluation of postprandial phosphorus concentrations in the plasma of the cat. Br J Nutr 121(3):270\u2013284. https:\/\/doi.org\/10.1017\/S0007114518003379","journal-title":"Br J Nutr"},{"issue":"1","key":"3160_CR229","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/s41598-023-28103-3","volume":"13","author":"B Battulga","year":"2023","unstructured":"Battulga B et al (2023) Correlative light and electron microscopic observation of calcium phosphate particles in a mouse kidney formed under a high-phosphate diet. Sci Rep 13(1):852. https:\/\/doi.org\/10.1038\/s41598-023-28103-3","journal-title":"Sci Rep"},{"issue":"6","key":"3160_CR230","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s00223-019-00525-0","volume":"104","author":"S Fukuda-Tatano","year":"2019","unstructured":"Fukuda-Tatano S et al (2019) Regulation of alpha-Klotho Expression by Dietary Phosphate During Growth Periods. Calcif Tissue Int 104(6):667\u2013678. https:\/\/doi.org\/10.1007\/s00223-019-00525-0","journal-title":"Calcif Tissue Int"},{"issue":"2","key":"3160_CR231","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s007950170004","volume":"34","author":"QL Liu","year":"2001","unstructured":"Liu QL, Sato S, Kishikawa T, Matsuzaki H, Yamanaka N (2001) Effectiveness of a traditional Chinese medicine, Wulingsan, in suppressing the development of nephrocalcinosis induced by a high phosphorus diet in young rats. Med Electron Microsc 34(2):103\u2013114. https:\/\/doi.org\/10.1007\/s007950170004","journal-title":"Med Electron Microsc"},{"key":"3160_CR232","unstructured":"Zalups RK, Haase P, Philbrick DJ (1983) Phosphate and the development of nephrocalcinosis in rats fed diets containing alpha protein. Am J Pathol 113(1):95\u2013106. [Online]. Available: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/6684888"},{"key":"3160_CR233","unstructured":"Woodard JC A morphologic and biochemical study of nutritional nephrocalcinosis in female rats fed semipurified diets. Am J Pathol 65(1):253\u201368. [Online]. Available: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/5096368"},{"issue":"3","key":"3160_CR234","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1079\/BJN20041065","volume":"91","author":"J Ritskes-Hoitinga","year":"2004","unstructured":"Ritskes-Hoitinga J, Grooten HN, Wienk KJ, Peters M, Lemmens AG, Beynen AC (2004) Lowering dietary phosphorus concentrations reduces kidney calcification, but does not adversely affect growth, mineral metabolism, and bone development in growing rabbits, (in eng). Br J Nutr 91(3):367\u2013376. https:\/\/doi.org\/10.1079\/BJN20041065 S0007114504000492 [pii]","journal-title":"Br J Nutr"},{"key":"3160_CR235","unstructured":"Zalups RK (1984) Age and the development of nephrocalcinosis induced by injections of neutral phosphate in rats. Acta Morphol Hung 32(2):121\u20135. [Online]. Available: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/6435400"},{"key":"3160_CR236","unstructured":"Haase P (1975) The development of nephrocalcinosis in the rat following injections of neutral sodium phosphate. J Anat 119(Pt 1):19\u201337. [Online]. Available: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1133087"},{"issue":"7","key":"3160_CR237","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.ekir.2019.03.021","volume":"4","author":"S Jahan","year":"2019","unstructured":"Jahan S, Lea-Henry T, Brown M, Karpe K (2019) An Unusual Case of Acute Phosphate Nephropathy. Kidney Int Rep 4(7):1023\u20131026. https:\/\/doi.org\/10.1016\/j.ekir.2019.03.021","journal-title":"Kidney Int Rep"},{"issue":"1","key":"3160_CR238","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.semnephrol.2018.10.004","volume":"39","author":"DE Leaf","year":"2019","unstructured":"Leaf DE, Christov M (2019) Dysregulated Mineral Metabolism in AKI. Semin Nephrol 39(1):41\u201356. https:\/\/doi.org\/10.1016\/j.semnephrol.2018.10.004","journal-title":"Semin Nephrol"},{"issue":"10","key":"3160_CR239","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1038\/ki.2009.308","volume":"76","author":"GS Markowitz","year":"2009","unstructured":"Markowitz GS, Perazella MA (2009) Acute phosphate nephropathy. Kidney Int 76(10):1027\u20131034. https:\/\/doi.org\/10.1038\/ki.2009.308","journal-title":"Kidney Int"},{"key":"3160_CR240","unstructured":"Vanner SJ, MacDonald PH, Paterson WG, Prentice RS, Da LR, Costa, Beck IT (1990) A randomized prospective trial comparing oral sodium phosphate with standard polyethylene glycol-based lavage solution (Golytely) in the preparation of patients for colonoscopy. Am J Gastroenterol 85(4):422\u20137, Apr [Online]. Available: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2183591"},{"key":"3160_CR241","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/BF02054413","volume":"37","author":"SM Cohen","year":"1994","unstructured":"Cohen SM et al (1994) Prospective, randomized, endoscopic-blinded trial comparing precolonoscopy bowel cleansing methods. Dis Colon Rectum 37:689\u2013696. https:\/\/doi.org\/10.1007\/BF02054413","journal-title":"Dis Colon Rectum"},{"key":"3160_CR242","unstructured":"Ahmed M, Raval P, Buganza G (1996) Oral sodium phosphate catharsis and acute renal failure. Am J Gastroenterol 91(6):1261\u20132. [Online]. Available: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8651185"},{"issue":"1","key":"3160_CR243","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/s0272-6386(97)90015-9","volume":"29","author":"A Fine","year":"1997","unstructured":"Fine A, Patterson J (Jan 1997) Severe hyperphosphatemia following phosphate administration for bowel preparation in patients with renal failure: two cases and a review of the literature. Am J Kidney Dis 29(1):103\u2013105. https:\/\/doi.org\/10.1016\/s0272-6386(97)90015-9","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"3160_CR244","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1159\/000013427","volume":"19","author":"M Orias","year":"1999","unstructured":"Orias M, Mahnensmith RL, Perazella MA (1999) Extreme hyperphosphatemia and acute renal failure after a phosphorus-containing bowel regimen. Am J Nephrol 19(1):60\u201363. https:\/\/doi.org\/10.1159\/000013427","journal-title":"Am J Nephrol"},{"issue":"4","key":"3160_CR245","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1097\/00004836-200204000-00017","volume":"34","author":"N Ullah","year":"2002","unstructured":"Ullah N, Yeh R, Ehrinpreis M (2002) Fatal hyperphosphatemia from a phosphosoda bowel preparation. J Clin Gastroenterol 34(4):457\u2013458. https:\/\/doi.org\/10.1097\/00004836-200204000-00017","journal-title":"J Clin Gastroenterol"},{"issue":"12","key":"3160_CR246","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1055\/s-2005-921155","volume":"37","author":"R Mishra 3rd","year":"2005","unstructured":"Mishra R, Kaufman D, Mattern J 3rd, Dutta SK (2005) Severe hyperphosphatemia and hypocalcemia caused by bowel preparation for colonoscopy using oral sodium phosphate in end-stage renal disease. Endoscopy 37(12):1259\u20131260. https:\/\/doi.org\/10.1055\/s-2005-921155","journal-title":"Endoscopy"},{"issue":"4","key":"3160_CR247","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1097\/MAJ.0b013e318167410c","volume":"336","author":"Y Ori","year":"2008","unstructured":"Ori Y et al (2008) Acute phosphate nephropathy-an emerging threat. Am J Med Sci 336(4):309\u2013314. https:\/\/doi.org\/10.1097\/MAJ.0b013e318167410c","journal-title":"Am J Med Sci"},{"issue":"11","key":"3160_CR248","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/ncpneph0939","volume":"4","author":"YH Lien","year":"2008","unstructured":"Lien YH (2008) Is bowel preparation before colonoscopy a risky business for the kidney? Nat Clin Pract Nephrol 4(11):606\u2013614. https:\/\/doi.org\/10.1038\/ncpneph0939","journal-title":"Nat Clin Pract Nephrol"},{"issue":"10","key":"3160_CR249","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1056\/NEJM200309043491020","volume":"349","author":"S Desmeules","year":"2003","unstructured":"Desmeules S, Bergeron MJ, Isenring P (2003) Acute phosphate nephropathy and renal failure. N Engl J Med 349(10):1006\u20131007. https:\/\/doi.org\/10.1056\/NEJM200309043491020","journal-title":"N Engl J Med"},{"issue":"6","key":"3160_CR250","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.humpath.2003.12.005","volume":"35","author":"GS Markowitz","year":"2004","unstructured":"Markowitz GS et al (2004) Renal failure due to acute nephrocalcinosis following oral sodium phosphate bowel cleansing. Hum Pathol 35(6):675\u2013684. https:\/\/doi.org\/10.1016\/j.humpath.2003.12.005","journal-title":"Hum Pathol"},{"issue":"11","key":"3160_CR251","doi-asserted-by":"publisher","first-page":"3389","DOI":"10.1681\/ASN.2005050496","volume":"16","author":"GS Markowitz","year":"2005","unstructured":"Markowitz GS, Stokes MB, Radhakrishnan J, D\u2019Agati VD (2005) Acute phosphate nephropathy following oral sodium phosphate bowel purgative: an underrecognized cause of chronic renal failure. J Am Soc Nephrol 16(11):3389\u20133396. https:\/\/doi.org\/10.1681\/ASN.2005050496","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"3160_CR252","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1093\/ndt\/gfh718","volume":"20","author":"GS Markowitz","year":"2005","unstructured":"Markowitz GS, Whelan J, D\u2019Agati VD (2005) Renal failure following bowel cleansing with a sodium phosphate purgative. Nephrol Dial Transpl 20(4):850\u2013851. https:\/\/doi.org\/10.1093\/ndt\/gfh718","journal-title":"Nephrol Dial Transpl"},{"issue":"1","key":"3160_CR253","doi-asserted-by":"publisher","first-page":"101","DOI":"10.5858\/2006-130-101-RFANAW","volume":"130","author":"G Gonlusen","year":"2006","unstructured":"Gonlusen G, Akgun H, Ertan A, Olivero J, Truong LD (2006) Renal failure and nephrocalcinosis associated with oral sodium phosphate bowel cleansing: clinical patterns and renal biopsy findings. Arch Pathol Lab Med 130(1):101\u2013106. https:\/\/doi.org\/10.5858\/2006-130-101-RFANAW","journal-title":"Arch Pathol Lab Med"},{"issue":"3","key":"3160_CR254","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.nefro.2016.02.010","volume":"36","author":"G Fernandez-Juarez","year":"2016","unstructured":"Fernandez-Juarez G et al (2016) Kidney injury after sodium phosphate solution beyond the acute renal failure. Nefrologia 36(3):243\u2013248. https:\/\/doi.org\/10.1016\/j.nefro.2016.02.010","journal-title":"Nefrologia"},{"issue":"2","key":"3160_CR255","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s40620-017-0442-6","volume":"31","author":"C Thongprayoon","year":"2018","unstructured":"Thongprayoon C, Cheungpasitporn W, Mao MA, Sakhuja A, Erickson SB (2018) Admission hyperphosphatemia increases the risk of acute kidney injury in hospitalized patients. J Nephrol 31(2):241\u2013247. https:\/\/doi.org\/10.1007\/s40620-017-0442-6","journal-title":"J Nephrol"},{"issue":"3","key":"3160_CR256","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1681\/ASN.0000000000000291","volume":"35","author":"AK Hamid","year":"2024","unstructured":"Hamid AK et al (2024) Phosphate restriction prevents metabolic acidosis and curbs rise in FGF23 and mortality in murine folic acid-induced AKI. J Am Soc Nephrol 35(3):261\u2013280. https:\/\/doi.org\/10.1681\/ASN.0000000000000291","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"3160_CR257","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/ki.2013.150","volume":"84","author":"M Christov","year":"2013","unstructured":"Christov M et al (2013) Plasma FGF23 levels increase rapidly after acute kidney injury. Kidney Int 84(4):776\u2013785. https:\/\/doi.org\/10.1038\/ki.2013.150","journal-title":"Kidney Int"},{"issue":"2","key":"3160_CR258","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.kint.2018.02.026","volume":"94","author":"K Durlacher-Betzer","year":"2018","unstructured":"Durlacher-Betzer K, Hassan A, Levi R, Axelrod J, Silver J, Naveh-Many T (2018) Interleukin-6 contributes to the increase in fibroblast growth factor 23 expression in acute and chronic kidney disease. Kidney Int 94(2):315\u2013325. https:\/\/doi.org\/10.1016\/j.kint.2018.02.026","journal-title":"Kidney Int"},{"issue":"6","key":"3160_CR259","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s00424-019-02255-6","volume":"471","author":"M Meurer","year":"2019","unstructured":"Meurer M, Hocherl K (2019) Renal ischemia-reperfusion injury impairs renal calcium, magnesium, and phosphate handling in mice. Pflugers Arch 471(6):901\u2013914. https:\/\/doi.org\/10.1007\/s00424-019-02255-6","journal-title":"Pflugers Arch"},{"issue":"2","key":"3160_CR260","doi-asserted-by":"publisher","first-page":"e0191290","DOI":"10.1371\/journal.pone.0191290","volume":"13","author":"SY Jung","year":"2018","unstructured":"Jung SY et al (2018) Phosphate is a potential biomarker of disease severity and predicts adverse outcomes in acute kidney injury patients undergoing continuous renal replacement therapy. PLoS ONE 13(2):e0191290. https:\/\/doi.org\/10.1371\/journal.pone.0191290","journal-title":"PLoS ONE"},{"issue":"3","key":"3160_CR261","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1053\/j.ajkd.2008.07.036","volume":"53","author":"IH de Boer","year":"2009","unstructured":"de Boer IH, Rue TC, Kestenbaum B (2009) Serum phosphorus concentrations in the third National Health and Nutrition Examination Survey (NHANES III). Am J Kidney Dis 53(3):399\u2013407. https:\/\/doi.org\/10.1053\/j.ajkd.2008.07.036","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"3160_CR262","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.ahj.2008.05.016","volume":"156","author":"RN Foley","year":"2008","unstructured":"Foley RN, Collins AJ, Ishani A, Kalra PA (2008) Calcium-phosphate levels and cardiovascular disease in community-dwelling adults: the Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J 156(3):556\u2013563. https:\/\/doi.org\/10.1016\/j.ahj.2008.05.016","journal-title":"Am Heart J"},{"issue":"2","key":"3160_CR263","doi-asserted-by":"publisher","first-page":"e852","DOI":"10.1210\/clinem\/dgab635","volume":"107","author":"C Volk","year":"2022","unstructured":"Volk C et al (2022) Acute effects of an inorganic phosphorus additive on mineral metabolism and cardiometabolic risk factors in healthy subjects. J Clin Endocrinol Metab 107(2):e852\u2013e864. https:\/\/doi.org\/10.1210\/clinem\/dgab635","journal-title":"J Clin Endocrinol Metab"},{"key":"3160_CR264","doi-asserted-by":"publisher","unstructured":"Ugrica M et al (2021) A chronic high phosphate intake in mice is detrimental for bone health without major renal alterations. Nephrol Dial Transpl. https:\/\/doi.org\/10.1093\/ndt\/gfab015","DOI":"10.1093\/ndt\/gfab015"},{"issue":"6","key":"3160_CR265","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/j.cmet.2015.09.002","volume":"22","author":"A Grabner","year":"2015","unstructured":"Grabner A et al (2015) Activation of cardiac fibroblast growth factor receptor 4 causes left ventricular hypertrophy. Cell Metab 22(6):1020\u20131032. https:\/\/doi.org\/10.1016\/j.cmet.2015.09.002","journal-title":"Cell Metab"},{"key":"3160_CR266","doi-asserted-by":"publisher","unstructured":"Czaya B et al (2022) Hyperphosphatemia increases inflammation to exacerbate anemia and skeletal muscle wasting independently of FGF23-FGFR4 signaling. Elife 11. https:\/\/doi.org\/10.7554\/eLife.74782","DOI":"10.7554\/eLife.74782"},{"key":"3160_CR267","doi-asserted-by":"publisher","unstructured":"Latic N, Peitzsch M, Zupcic A, Pietzsch J, Erben RG (2022) Long-term excessive dietary phosphate intake increases arterial blood pressure, activates the renin-angiotensin-aldosterone system, and stimulates sympathetic tone in mice. Biomedicines 10(10). https:\/\/doi.org\/10.3390\/biomedicines10102510","DOI":"10.3390\/biomedicines10102510"},{"issue":"8","key":"3160_CR268","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1093\/jn\/122.8.1682","volume":"122","author":"J Van Ritskes-Hoitinga","year":"1992","unstructured":"Ritskes-Hoitinga J, Mathot JN, Van Zutphen LF, Beynen AC (1992) Inbred strains of rats have differential sensitivity to dietary phosphorus-induced nephrocalcinosis. J Nutr 122(8):1682\u20131692. https:\/\/doi.org\/10.1093\/jn\/122.8.1682","journal-title":"J Nutr"},{"key":"3160_CR269","unstructured":"Geary CP, Cousins FB (1969) An oestrogen-linked nephrocalcinosis in rats. Br J Exp Pathol 50(5):507\u201315. [Online]. Available: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/5348008"},{"issue":"2","key":"3160_CR270","doi-asserted-by":"publisher","first-page":"444","DOI":"10.3945\/ajcn.114.102715","volume":"102","author":"LW Moore","year":"2015","unstructured":"Moore LW, Nolte JV, Gaber AO, Suki WN (2015) Association of dietary phosphate and serum phosphorus concentration by levels of kidney function. Am J Clin Nutr 102(2):444\u2013453. https:\/\/doi.org\/10.3945\/ajcn.114.102715","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"3160_CR271","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3164\/jcbn.20-23","volume":"68","author":"Y Saito","year":"2021","unstructured":"Saito Y, Sakuma M, Narishima Y, Yoshida T, Kumagai H, Arai H (2021) Greater consumption of noodle is associated with higher serum phosphorus levels: a cross-sectional study on healthy participants. J Clin Biochem Nutr 68(1):78\u201385. https:\/\/doi.org\/10.3164\/jcbn.20-23","journal-title":"J Clin Biochem Nutr"},{"issue":"2","key":"3160_CR272","doi-asserted-by":"publisher","first-page":"257","DOI":"10.2215\/CJN.05040610","volume":"6","author":"SM Moe","year":"2011","unstructured":"Moe SM et al (2011) Vegetarian compared with meat dietary protein source and phosphorus homeostasis in chronic kidney disease. Clin J Am Soc Nephrol 6(2):257\u2013264. https:\/\/doi.org\/10.2215\/CJN.05040610","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"3160_CR273","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s10653-015-9768-y","volume":"38","author":"SJ Wimalawansa","year":"2016","unstructured":"Wimalawansa SJ (2016) The role of ions, heavy metals, fluoride, and agrochemicals: critical evaluation of potential aetiological factors of chronic kidney disease of multifactorial origin (CKDmfo\/CKDu) and recommendations for its eradication. Environ Geochem Health 38(3):639\u2013678. https:\/\/doi.org\/10.1007\/s10653-015-9768-y","journal-title":"Environ Geochem Health"},{"issue":"10","key":"3160_CR274","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1007\/s10661-016-5524-8","volume":"188","author":"KE Levine","year":"2016","unstructured":"Levine KE et al (2016) Quest to identify geochemical risk factors associated with chronic kidney disease of unknown etiology (CKDu) in an endemic region of Sri Lanka-a multimedia laboratory analysis of biological, food, and environmental samples. Environ Monit Assess 188(10):548. https:\/\/doi.org\/10.1007\/s10661-016-5524-8","journal-title":"Environ Monit Assess"},{"key":"3160_CR275","doi-asserted-by":"publisher","first-page":"110270","DOI":"10.1016\/j.envres.2020.110270","volume":"192","author":"JH Redmon","year":"2021","unstructured":"Redmon JH, Levine KE, Lebov J, Harrington J, Kondash AJ (2021) A comparative review: Chronic Kidney Disease of unknown etiology (CKDu) research conducted in Latin America versus Asia. Environ Res 192:110270. https:\/\/doi.org\/10.1016\/j.envres.2020.110270","journal-title":"Environ Res"},{"issue":"11","key":"3160_CR276","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1016\/j.ekir.2020.08.032","volume":"5","author":"S Parameswaran","year":"2020","unstructured":"Parameswaran S et al (2020) A Newly Recognized Endemic Region of CKD of Undetermined Etiology (CKDu) in South India-Tondaimandalam Nephropathy. Kidney Int Rep 5(11):2066\u20132073. https:\/\/doi.org\/10.1016\/j.ekir.2020.08.032","journal-title":"Kidney Int Rep"},{"issue":"1","key":"3160_CR277","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/s40001-023-01162-y","volume":"28","author":"SJ Wimalawansa","year":"2023","unstructured":"Wimalawansa SJ, Dissanayake CB (2023) Nanocrystal-induced chronic tubular-nephropathy in tropical countries: diagnosis, mitigation, and eradication. Eur J Med Res 28(1):221. https:\/\/doi.org\/10.1186\/s40001-023-01162-y","journal-title":"Eur J Med Res"},{"key":"3160_CR278","doi-asserted-by":"crossref","unstructured":"Shipley ER, Vlahos P, Chandrajith R, Wijerathna P (2022) Agrochemical exposure in Sri Lankan inland water systems. Environ Adv 7. [Online]. Available: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S2666765721001216","DOI":"10.1016\/j.envadv.2021.100150"},{"key":"3160_CR279","doi-asserted-by":"crossref","unstructured":"Shaji E, Sarath KV, Santosh M, Krishnaprasad PK, Arya BK, Babu MS (2024) Fluoride contamination in groundwater: A global review of the status, processes, challenges, and remedial measures. Geosci Front 15(2) [Online]. Available: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1674987123002013","DOI":"10.1016\/j.gsf.2023.101734"},{"issue":"4","key":"3160_CR280","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1007\/s002400100192","volume":"29","author":"PP Singh","year":"2001","unstructured":"Singh PP, Barjatiya MK, Dhing S, Bhatnagar R, Kothari S, Dhar V (2001) Evidence suggesting that high intake of fluoride provokes nephrolithiasis in tribal populations. Urol Res 29(4):238\u2013244. https:\/\/doi.org\/10.1007\/s002400100192","journal-title":"Urol Res"},{"key":"3160_CR281","doi-asserted-by":"publisher","first-page":"119643","DOI":"10.1016\/j.ecoenv.2025.119643","volume":"309","author":"N Pongsapipatana","year":"2026","unstructured":"Pongsapipatana N et al (2026) Urinary proteomic biomarkers of systemic fluoride exposure in children. Ecotoxicol Environ Saf 309:119643. https:\/\/doi.org\/10.1016\/j.ecoenv.2025.119643","journal-title":"Ecotoxicol Environ Saf"},{"issue":"2","key":"3160_CR282","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/0006-2944(83)90081-9","volume":"30","author":"A Anasuya","year":"1983","unstructured":"Anasuya A, Narasinga Rao BS (1983) Effect of fluoride, silicon, and magnesium on the mineralizing capacity of an inorganic medium and stone formers urine tested by a modified in vitro method. Biochem Med 30(2):146\u2013156. https:\/\/doi.org\/10.1016\/0006-2944(83)90081-9","journal-title":"Biochem Med"},{"key":"3160_CR283","doi-asserted-by":"crossref","unstructured":"Yusenko EP, Kapsargin FP, Nesterenko PN (2014) Determination of fluoride ions in urinary stones by ion chromatography. J Analytical Chem 69:474\u2013479, [Online]. Available: https:\/\/link.springer.com\/article\/10.1134\/S1061934814050128","DOI":"10.1134\/S1061934814050128"},{"key":"3160_CR284","unstructured":"Li LC, Zhang YS, Hu RZ, Zhou XC (1992) Inhibitory effect of fluoride on renal stone formation in rats. Urol Int 48(3):336\u201341, [Online]. Available: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1589929"},{"issue":"2","key":"3160_CR285","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1681\/ASN.2014101025","volume":"27","author":"KP Schlingmann","year":"2016","unstructured":"Schlingmann KP et al (2016) Autosomal-recessive mutations in SLC34A1 encoding sodium-phosphate cotransporter 2A cause idiopathic infantile hypercalcemia. J Am Soc Nephrol 27(2):604\u2013614. https:\/\/doi.org\/10.1681\/ASN.2014101025","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"3160_CR286","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s00424-018-2246-5","volume":"471","author":"E Lederer","year":"2019","unstructured":"Lederer E, Wagner CA (2019) Clinical aspects of the phosphate transporters NaPi-IIa and NaPi-IIb: mutations and disease associations. Pflugers Arch 471(1):137\u2013148. https:\/\/doi.org\/10.1007\/s00424-018-2246-5","journal-title":"Pflugers Arch"},{"key":"3160_CR287","doi-asserted-by":"publisher","unstructured":"Mura-Escorche G, Garcia-Suarez LC, Lebredo-Alvarez I, Ramos-Trujillo E, Claverie-Martin F (2025) Identification of a novel homozygous SLC34A1 missense mutation and a heterozygous SLC34A3 deletion in an infant with nephrocalcinosis, failure to thrive, and hypercalcemia. Int J Mol Sci 26(17). https:\/\/doi.org\/10.3390\/ijms26178541","DOI":"10.3390\/ijms26178541"},{"issue":"2","key":"3160_CR288","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1086\/499409","volume":"78","author":"C Bergwitz","year":"2006","unstructured":"Bergwitz C et al (2006) SLC34A3 mutations in patients with hereditary hypophosphatemic rickets with hypercalciuria predict a key role for the sodium-phosphate cotransporter NaPi-IIc in maintaining phosphate homeostasis. Am J Hum Genet 78(2):179\u2013192. https:\/\/doi.org\/10.1086\/499409","journal-title":"Am J Hum Genet"},{"issue":"2","key":"3160_CR289","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1086\/499410","volume":"78","author":"B Lorenz-Depiereux","year":"2006","unstructured":"Lorenz-Depiereux B et al (2006) Hereditary hypophosphatemic rickets with hypercalciuria is caused by mutations in the sodium-phosphate cotransporter gene SLC34A3. Am J Hum Genet 78(2):193\u2013201. https:\/\/doi.org\/10.1086\/499410","journal-title":"Am J Hum Genet"},{"issue":"1","key":"3160_CR290","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.kint.2024.08.035","volume":"107","author":"M Brunkhorst","year":"2025","unstructured":"Brunkhorst M et al (2025) Presentation and outcome in carriers of pathogenic variants in SLC34A1 and SLC34A3 encoding sodium-phosphate transporter NPT 2a and 2c. Kidney Int 107(1):116\u2013129. https:\/\/doi.org\/10.1016\/j.kint.2024.08.035","journal-title":"Kidney Int"},{"issue":"11","key":"3160_CR291","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1681\/ASN.0000000000000204","volume":"34","author":"C Nwachukwu","year":"2023","unstructured":"Nwachukwu C, Singh G, Moore B, Strande NT, Bucaloiu ID, Chang AR (2023) Risk of nephrolithiasis in adults heterozygous for SLC34A3 Ser192Leu in an unselected health system cohort. J Am Soc Nephrol 34(11):1819\u20131821. https:\/\/doi.org\/10.1681\/ASN.0000000000000204","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"3160_CR292","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.1681\/ASN.2013101085","volume":"25","author":"D Dasgupta","year":"2014","unstructured":"Dasgupta D et al (2014) Mutations in SLC34A3\/NPT2c are associated with kidney stones and nephrocalcinosis. J Am Soc Nephrol 25(10):2366\u20132375. https:\/\/doi.org\/10.1681\/ASN.2013101085","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"3160_CR293","doi-asserted-by":"publisher","first-page":"100419","DOI":"10.1016\/j.xkme.2022.100419","volume":"4","author":"C Hanna","year":"2022","unstructured":"Hanna C et al (2022) Kidney cysts in hypophosphatemic rickets with hypercalciuria: A case series. Kidney Med 4(3):100419. https:\/\/doi.org\/10.1016\/j.xkme.2022.100419","journal-title":"Kidney Med"},{"issue":"5","key":"3160_CR294","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/ng.568","volume":"42","author":"A Kottgen","year":"2010","unstructured":"Kottgen A et al (2010) New loci associated with kidney function and chronic kidney disease. Nat Genet 42(5):376\u2013384. https:\/\/doi.org\/10.1038\/ng.568","journal-title":"Nat Genet"},{"key":"3160_CR295","doi-asserted-by":"publisher","first-page":"10023","DOI":"10.1038\/ncomms10023","volume":"7","author":"C Pattaro","year":"2016","unstructured":"Pattaro C et al (2016) Genetic associations at 53 loci highlight cell types and biological pathways relevant for kidney function. Nat Commun 7:10023. https:\/\/doi.org\/10.1038\/ncomms10023","journal-title":"Nat Commun"},{"issue":"6","key":"3160_CR296","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1038\/s41588-019-0407-x","volume":"51","author":"M Wuttke","year":"2019","unstructured":"Wuttke M et al (2019) A catalog of genetic loci associated with kidney function from analyses of a million individuals. Nat Genet 51(6):957\u2013972. https:\/\/doi.org\/10.1038\/s41588-019-0407-x","journal-title":"Nat Genet"},{"issue":"6734","key":"3160_CR297","doi-asserted-by":"publisher","first-page":"eadp4753","DOI":"10.1126\/science.adp4753","volume":"387","author":"H Liu","year":"2025","unstructured":"Liu H et al (2025) Kidney multiome-based genetic scorecard reveals convergent coding and regulatory variants. Science 387(6734):eadp4753. https:\/\/doi.org\/10.1126\/science.adp4753","journal-title":"Science"},{"issue":"3","key":"3160_CR298","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1681\/ASN.2014010028","volume":"26","author":"N Ledo","year":"2015","unstructured":"Ledo N et al (2015) Functional genomic annotation of genetic risk loci highlights inflammation and epithelial biology networks in CKD. J Am Soc Nephrol 26(3):692\u2013714. https:\/\/doi.org\/10.1681\/ASN.2014010028","journal-title":"J Am Soc Nephrol"},{"key":"3160_CR299","doi-asserted-by":"crossref","unstructured":"Beck L, Karaplis AC, Amizuka N, Hewson AS, Ozawa H, Tenenhouse HS (1998) Targeted inactivation of Npt2 in mice leads to severe renal phosphate wasting, hypercalciuria, and skeletal abnormalities. Proc Natl Acad Sci USA 95(9):5372\u20137. [Online]. Available: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9560283","DOI":"10.1073\/pnas.95.9.5372"},{"issue":"3","key":"3160_CR300","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s00223-023-01172-2","volume":"114","author":"A Bosman","year":"2024","unstructured":"Bosman A et al (2024) Disease manifestations and complications in Dutch X-linked hypophosphatemia patients. Calcif Tissue Int 114(3):255\u2013266. https:\/\/doi.org\/10.1007\/s00223-023-01172-2","journal-title":"Calcif Tissue Int"},{"issue":"10","key":"3160_CR301","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1093\/jbmr\/zjae127","volume":"39","author":"AA Portale","year":"2024","unstructured":"Portale AA et al (2024) Nephrocalcinosis and kidney function in children and adults with X-linked hypophosphatemia: baseline results from a large longitudinal study. J Bone Min Res 39(10):1493\u20131502. https:\/\/doi.org\/10.1093\/jbmr\/zjae127","journal-title":"J Bone Min Res"},{"issue":"8","key":"3160_CR302","doi-asserted-by":"publisher","first-page":"e70104","DOI":"10.1111\/nep.70104","volume":"30","author":"M Muto","year":"2025","unstructured":"Muto M et al (2025) A novel PHEX mutation in X-Linked hypophosphataemic rickets with reduced expression of NaPi-IIa and NaPi-IIc in the proximal tubules: A case report. Nephrol (Carlton) 30(8):e70104. https:\/\/doi.org\/10.1111\/nep.70104","journal-title":"Nephrol (Carlton)"},{"key":"3160_CR303","doi-asserted-by":"publisher","unstructured":"Lemoine S et al (2025) Challenges in estimating renal function in X-linked hypophosphatemia because of formula overestimation and FGF23 effects. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/clinem\/dgaf459","DOI":"10.1210\/clinem\/dgaf459"},{"issue":"9","key":"3160_CR304","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.1172\/JCI31330","volume":"117","author":"S Ichikawa","year":"2007","unstructured":"Ichikawa S et al (2007) A homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis. J Clin Invest 117(9):2684\u20132691. https:\/\/doi.org\/10.1172\/JCI31330","journal-title":"J Clin Invest"},{"issue":"4","key":"3160_CR305","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1210\/jc.2004-2302","volume":"90","author":"S Ichikawa","year":"2005","unstructured":"Ichikawa S, Lyles KW, Econs MJ (2005) A novel GALNT3 mutation in a pseudoautosomal dominant form of tumoral calcinosis: evidence that the disorder is autosomal recessive. J Clin Endocrinol Metab 90(4):2420\u20132423. https:\/\/doi.org\/10.1210\/jc.2004-2302","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"3160_CR306","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1093\/hmg\/ddi034","volume":"14","author":"A Benet-Pages","year":"2005","unstructured":"Benet-Pages A, Orlik P, Strom TM, Lorenz-Depiereux B (2005) An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia. Hum Mol Genet 14(3):385\u2013390. https:\/\/doi.org\/10.1093\/hmg\/ddi034","journal-title":"Hum Mol Genet"},{"issue":"6","key":"3160_CR307","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/ng1358","volume":"36","author":"O Topaz","year":"2004","unstructured":"Topaz O et al (2004) Mutations in GALNT3, encoding a protein involved in O-linked glycosylation, cause familial tumoral calcinosis. Nat Genet 36(6):579\u2013581. https:\/\/doi.org\/10.1038\/ng1358","journal-title":"Nat Genet"},{"key":"3160_CR308","doi-asserted-by":"publisher","first-page":"293","DOI":"10.3389\/fendo.2020.00293","volume":"11","author":"AM Boyce","year":"2020","unstructured":"Boyce AM, Lee AE, Roszko KL, Gafni RI (2020) Hyperphosphatemic Tumoral Calcinosis: Pathogenesis, Clinical Presentation, and Challenges in Management. Front Endocrinol (Lausanne) 11:293. https:\/\/doi.org\/10.3389\/fendo.2020.00293","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"3160_CR309","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s00439-005-0026-8","volume":"118","author":"I Chefetz","year":"2005","unstructured":"Chefetz I et al (2005) A novel homozygous missense mutation in FGF23 causes Familial Tumoral Calcinosis associated with disseminated visceral calcification. Hum Genet 118(2):261\u2013266. https:\/\/doi.org\/10.1007\/s00439-005-0026-8","journal-title":"Hum Genet"},{"issue":"11","key":"3160_CR310","doi-asserted-by":"publisher","first-page":"4267","DOI":"10.1210\/jc.2009-0961","volume":"94","author":"C Bergwitz","year":"2009","unstructured":"Bergwitz C et al (2009) Defective O-glycosylation due to a novel homozygous S129P mutation is associated with lack of fibroblast growth factor 23 secretion and tumoral calcinosis. J Clin Endocrinol Metab 94(11):4267\u20134274. https:\/\/doi.org\/10.1210\/jc.2009-0961","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"3160_CR311","doi-asserted-by":"publisher","first-page":"3562","DOI":"10.1096\/fj.09-152488","volume":"24","author":"M Ohnishi","year":"2010","unstructured":"Ohnishi M, Razzaque MS (2010) Dietary and genetic evidence for phosphate toxicity accelerating mammalian aging. FASEB J 24(9):3562\u20133571. https:\/\/doi.org\/10.1096\/fj.09-152488","journal-title":"FASEB J"},{"issue":"12","key":"3160_CR312","doi-asserted-by":"publisher","first-page":"3182","DOI":"10.1093\/jn\/131.12.3182","volume":"131","author":"K Morishita","year":"2001","unstructured":"Morishita K et al (2001) The progression of aging in klotho mutant mice can be modified by dietary phosphorus and zinc. J Nutr 131(12):3182\u20133188. https:\/\/doi.org\/10.1093\/jn\/131.12.3182","journal-title":"J Nutr"},{"issue":"1","key":"3160_CR313","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1159\/000443411","volume":"41","author":"CB Leibrock","year":"2016","unstructured":"Leibrock CB et al (2016) Partial Reversal of Tissue Calcification and Extension of Life Span following Ammonium Nitrate Treatment of Klotho-Deficient Mice. Kidney Blood Press Res 41(1):99\u2013107. https:\/\/doi.org\/10.1159\/000443411","journal-title":"Kidney Blood Press Res"},{"issue":"10","key":"3160_CR314","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1681\/ASN.2014030230","volume":"26","author":"CB Leibrock","year":"2015","unstructured":"Leibrock CB et al (2015) NH4Cl treatment prevents tissue calcification in klotho deficiency. J Am Soc Nephrol 26(10):2423\u20132433. https:\/\/doi.org\/10.1681\/ASN.2014030230","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"3160_CR315","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1172\/JCI64093","volume":"123","author":"J Voelkl","year":"2013","unstructured":"Voelkl J et al (2013) Spironolactone ameliorates PIT1-dependent vascular osteoinduction in klotho-hypomorphic mice. J Clin Invest 123(2):812\u2013822. https:\/\/doi.org\/10.1172\/JCI64093","journal-title":"J Clin Invest"},{"issue":"1","key":"3160_CR316","doi-asserted-by":"publisher","first-page":"F102","DOI":"10.1152\/ajprenal.00037.2015","volume":"310","author":"CB Leibrock","year":"2016","unstructured":"Leibrock CB, Voelkl J, Kohlhofer U, Quintanilla-Martinez L, Kuro OM, Lang F (2016) Bicarbonate-sensitive calcification and lifespan of klotho-deficient mice. Am J Physiol Ren Physiol 310(1):F102\u2013F108. https:\/\/doi.org\/10.1152\/ajprenal.00037.2015","journal-title":"Am J Physiol Ren Physiol"},{"issue":"5742","key":"3160_CR317","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1126\/science.1112766","volume":"309","author":"H Kurosu","year":"2005","unstructured":"Kurosu H et al (2005) Suppression of aging in mice by the hormone Klotho. Science 309(5742):1829\u20131833. https:\/\/doi.org\/10.1126\/science.1112766","journal-title":"Science"},{"issue":"12","key":"3160_CR318","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1016\/j.mad.2005.07.007","volume":"126","author":"H Masuda","year":"2005","unstructured":"Masuda H, Chikuda H, Suga T, Kawaguchi H, Kuro-o M (2005) Regulation of multiple ageing-like phenotypes by inducible klotho gene expression in klotho mutant mice. Mech Ageing Dev 126(12):1274\u20131283. https:\/\/doi.org\/10.1016\/j.mad.2005.07.007","journal-title":"Mech Ageing Dev"},{"issue":"10","key":"3160_CR319","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1002\/jbmr.3195","volume":"32","author":"O Andrukhova","year":"2017","unstructured":"Andrukhova O et al (2017) Klotho Lacks an FGF23-Independent Role in Mineral Homeostasis. J Bone Min Res 32(10):2049\u20132061. https:\/\/doi.org\/10.1002\/jbmr.3195","journal-title":"J Bone Min Res"},{"key":"3160_CR320","doi-asserted-by":"publisher","first-page":"7090","DOI":"10.1073\/pnas.1321942111","volume":"111","author":"M Eren","year":"2014","unstructured":"Eren M et al (2014) PAI-1-regulated extracellular proteolysis governs senescence and survival in Klotho mice. Proc Natl Acad Sci USA 111:7090\u20137095. https:\/\/doi.org\/10.1073\/pnas.1321942111","journal-title":"Proc Natl Acad Sci USA"},{"key":"3160_CR321","doi-asserted-by":"publisher","first-page":"5847","DOI":"10.1038\/srep05847","volume":"4","author":"Y Nabeshima","year":"2014","unstructured":"Nabeshima Y et al (2014) Calpain 1 inhibitor BDA-410 ameliorates alpha-klotho-deficiency phenotypes resembling human aging-related syndromes. Sci Rep 4:5847. https:\/\/doi.org\/10.1038\/srep05847","journal-title":"Sci Rep"},{"issue":"6","key":"3160_CR322","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1161\/CIRCGENETICS.108.847814","volume":"2","author":"M Ohnishi","year":"2009","unstructured":"Ohnishi M, Nakatani T, Lanske B, Razzaque MS (2009) In vivo genetic evidence for suppressing vascular and soft-tissue calcification through the reduction of serum phosphate levels, even in the presence of high serum calcium and 1,25-dihydroxyvitamin d levels. Circ Cardiovasc Genet 2(6):583\u2013590. https:\/\/doi.org\/10.1161\/CIRCGENETICS.108.847814","journal-title":"Circ Cardiovasc Genet"},{"issue":"9","key":"3160_CR323","doi-asserted-by":"publisher","first-page":"2810","DOI":"10.1681\/ASN.2015040446","volume":"27","author":"M Kawai","year":"2016","unstructured":"Kawai M, Kinoshita S, Ozono K, Michigami T (2016) Inorganic Phosphate Activates the AKT\/mTORC1 Pathway and Shortens the Life Span of an alpha\u2013Klotho-Deficient Model. J Am Soc Nephrol 27(9):2810\u20132824. https:\/\/doi.org\/10.1681\/ASN.2015040446","journal-title":"J Am Soc Nephrol"},{"key":"3160_CR324","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.matbio.2004.09.007","volume":"23","author":"D Sitara","year":"2004","unstructured":"Sitara D et al (2004) Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice. Matrix Biol 23:421\u2013432. https:\/\/doi.org\/10.1016\/j.matbio.2004.09.007","journal-title":"Matrix Biol"},{"issue":"6","key":"3160_CR325","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1096\/fj.05-5432fje","volume":"20","author":"MS Razzaque","year":"2006","unstructured":"Razzaque MS, Sitara D, Taguchi T, St-Arnaud R, Lanske B (2006) Premature aging-like phenotype in fibroblast growth factor 23 null mice is a vitamin D-mediated process. FASEB J 20(6):720\u2013722. https:\/\/doi.org\/10.1096\/fj.05-5432fje","journal-title":"FASEB J"},{"issue":"3","key":"3160_CR326","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1002\/path.2409","volume":"216","author":"S DeLuca","year":"2008","unstructured":"DeLuca S et al (2008) Amelioration of the premature ageing-like features of Fgf-23 knockout mice by genetically restoring the systemic actions of FGF-23. J Pathol 216(3):345\u2013355. https:\/\/doi.org\/10.1002\/path.2409","journal-title":"J Pathol"},{"issue":"1","key":"3160_CR327","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.arr.2007.02.002","volume":"6","author":"B Lanske","year":"2007","unstructured":"Lanske B, Razzaque MS (2007) Premature aging in klotho mutant mice: cause or consequence? Ageing Res Rev 6(1):73\u201379. https:\/\/doi.org\/10.1016\/j.arr.2007.02.002","journal-title":"Ageing Res Rev"},{"issue":"10","key":"3160_CR328","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1093\/ndt\/gfh991","volume":"20","author":"MS Razzaque","year":"2005","unstructured":"Razzaque MS, St-Arnaud R, Taguchi T, Lanske B (2005) FGF-23, vitamin D and calcification: the unholy triad. Nephrol Dial Transpl 20(10):2032\u20132035. https:\/\/doi.org\/10.1093\/ndt\/gfh991","journal-title":"Nephrol Dial Transpl"},{"issue":"11","key":"3160_CR329","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1007\/s00198-018-4618-2","volume":"29","author":"G Marcucci","year":"2018","unstructured":"Marcucci G et al (2018) Phosphate wasting disorders in adults. Osteoporos Int 29(11):2369\u20132387. https:\/\/doi.org\/10.1007\/s00198-018-4618-2","journal-title":"Osteoporos Int"},{"issue":"2","key":"3160_CR330","doi-asserted-by":"publisher","first-page":"101839","DOI":"10.1016\/j.beem.2023.101839","volume":"38","author":"SB Thakare","year":"2024","unstructured":"Thakare SB, Jamale TE, Memon SS (2024) Acquired disorders of phosphaturia: Beyond tumor-induced osteomalacia. Best Pract Res Clin Endocrinol Metab 38(2):101839. https:\/\/doi.org\/10.1016\/j.beem.2023.101839","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"10","key":"3160_CR331","doi-asserted-by":"publisher","first-page":"101204","DOI":"10.1016\/j.xcrm.2023.101204","volume":"4","author":"V Subbiah","year":"2023","unstructured":"Subbiah V, Verstovsek S (2023) Clinical development and management of adverse events associated with FGFR inhibitors. Cell Rep Med 4(10):101204. https:\/\/doi.org\/10.1016\/j.xcrm.2023.101204","journal-title":"Cell Rep Med"},{"issue":"5","key":"3160_CR332","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.aace.2022.07.001","volume":"8","author":"A Puar","year":"2022","unstructured":"Puar A et al (2022) Hyperphosphatemic tumoral calcinosis with pemigatinib use. AACE Clin Case Rep 8(5):217\u2013220. https:\/\/doi.org\/10.1016\/j.aace.2022.07.001","journal-title":"AACE Clin Case Rep"},{"issue":"5","key":"3160_CR333","doi-asserted-by":"publisher","first-page":"e83773","DOI":"10.7759\/cureus.83773","volume":"17","author":"B Ghimire","year":"2025","unstructured":"Ghimire B, Gor D, Abbas O, Diab M (2025) Calcinosis cutis with selective fibroblast growth factor receptor inhibitors: A case report and review of literature. Cureus 17(5):e83773. https:\/\/doi.org\/10.7759\/cureus.83773","journal-title":"Cureus"},{"issue":"2","key":"3160_CR334","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1093\/toxsci\/kft161","volume":"135","author":"GM Yanochko","year":"2013","unstructured":"Yanochko GM et al (2013) Pan-FGFR inhibition leads to blockade of FGF23 signaling, soft tissue mineralization, and cardiovascular dysfunction. Toxicol Sci 135(2):451\u2013464. https:\/\/doi.org\/10.1093\/toxsci\/kft161","journal-title":"Toxicol Sci"},{"key":"3160_CR335","doi-asserted-by":"publisher","first-page":"e0228503","DOI":"10.1371\/journal.pone.0228503","volume":"15","author":"M Herrmann","year":"2020","unstructured":"Herrmann M et al (2020) Lumenal calcification and microvasculopathy in fetuin-A-deficient mice lead to multiple organ morbidity. PLoS ONE 15:e0228503. no. 210.1371\/journal.pone.0228503","journal-title":"PLoS ONE"},{"issue":"3","key":"3160_CR336","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1172\/JCI17202","volume":"112","author":"C Schafer","year":"2003","unstructured":"Schafer C et al (2003) The serum protein alpha 2-Heremans-Schmid glycoprotein\/fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest 112(3):357\u2013366. https:\/\/doi.org\/10.1172\/JCI17202","journal-title":"J Clin Invest"},{"key":"3160_CR337","doi-asserted-by":"publisher","first-page":"e0228938","DOI":"10.1371\/journal.pone.0228938","volume":"15","author":"A Babler","year":"2020","unstructured":"Babler A et al (2020) Microvasculopathy and soft tissue calcification in mice are governed by fetuin-A, magnesium and pyrophosphate. PLoS ONE 15:e0228938. no. 210.1371\/journal.pone.0228938","journal-title":"PLoS ONE"},{"key":"3160_CR338","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.coph.2016.03.003","volume":"28","author":"IR Orriss","year":"2016","unstructured":"Orriss IR, Arnett TR, Russell RG (2016) Pyrophosphate: a key inhibitor of mineralisation. Curr Opin Pharmacol 28:57\u201368. https:\/\/doi.org\/10.1016\/j.coph.2016.03.003","journal-title":"Curr Opin Pharmacol"},{"issue":"9","key":"3160_CR339","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1161\/ATVBAHA.114.304017","volume":"34","author":"RS Jansen","year":"2014","unstructured":"Jansen RS et al (2014) ABCC6-mediated ATP secretion by the liver is the main source of the mineralization inhibitor inorganic pyrophosphate in the systemic circulation-brief report. Arterioscler Thromb Vasc Biol 34(9):1985\u20131989. https:\/\/doi.org\/10.1161\/ATVBAHA.114.304017","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"3160_CR340","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1146\/annurev-pathmechdis-051222-121126","volume":"19","author":"CR Ferreira","year":"2024","unstructured":"Ferreira CR, Carpenter TO, Braddock DT (2024) ENPP1 in blood and bone: Skeletal and soft tissue diseases induced by ENPP1 deficiency. Annu Rev Pathol 19:507\u2013540. https:\/\/doi.org\/10.1146\/annurev-pathmechdis-051222-121126","journal-title":"Annu Rev Pathol"},{"issue":"12","key":"3160_CR341","doi-asserted-by":"publisher","first-page":"7608","DOI":"10.1074\/jbc.M708290200","volume":"283","author":"Z Aherrahrou","year":"2008","unstructured":"Aherrahrou Z et al (2008) An alternative splice variant in Abcc6, the gene causing dystrophic calcification, leads to protein deficiency in C3H\/He mice. J Biol Chem 283(12):7608\u20137615. https:\/\/doi.org\/10.1074\/jbc.M708290200","journal-title":"J Biol Chem"},{"key":"3160_CR342","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1093\/hmg\/ddi183","volume":"14","author":"TG Gorgels","year":"2005","unstructured":"Gorgels TG et al (2005) Disruption of Abcc6 in the mouse: novel insight in the pathogenesis of pseudoxanthoma elasticum. Hum Mol Genet 14:1763\u20131773. https:\/\/doi.org\/10.1093\/hmg\/ddi183","journal-title":"Hum Mol Genet"},{"issue":"18","key":"3160_CR343","doi-asserted-by":"publisher","first-page":"8299","DOI":"10.1128\/MCB.25.18.8299-8310.2005","volume":"25","author":"JF Klement","year":"2005","unstructured":"Klement JF et al (2005) Targeted ablation of the abcc6 gene results in ectopic mineralization of connective tissues. Mol Cell Biol 25(18):8299\u20138310. https:\/\/doi.org\/10.1128\/MCB.25.18.8299-8310.2005","journal-title":"Mol Cell Biol"},{"issue":"2","key":"3160_CR344","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1177\/030098588802500202","volume":"25","author":"JI Everitt","year":"1988","unstructured":"Everitt JI, Olson LM, Mangum JB, Visek WJ (1988) High mortality with severe dystrophic cardiac calcinosis in C3H\/OUJ mice fed high fat purified diets. Vet Pathol 25(2):113\u2013118. https:\/\/doi.org\/10.1177\/030098588802500202","journal-title":"Vet Pathol"},{"key":"3160_CR345","unstructured":"Eaton GJ, Custer RP, Johnson FN, Stabenow KT (1978) Dystrophic cardiac calcinosis in mice: genetic, hormonal, and dietary influences. Am J Pathol 90(1):173\u201386. [Online]. Available: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/145807"},{"issue":"8","key":"3160_CR346","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1002\/jbmr.4315","volume":"36","author":"Z Cheng","year":"2021","unstructured":"Cheng Z et al (2021) INZ-701 prevents ectopic tissue calcification and restores bone architecture and growth in ENPP1-deficient mice. J Bone Min Res 36(8):1594\u20131604. https:\/\/doi.org\/10.1002\/jbmr.4315","journal-title":"J Bone Min Res"},{"issue":"5","key":"3160_CR347","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1242\/dmm.012765","volume":"6","author":"Q Li","year":"2013","unstructured":"Li Q, Guo H, Chou DW, Berndt A, Sundberg JP, Uitto J (2013) Mutant Enpp1asj mice as a model for generalized arterial calcification of infancy. Dis Model Mech 6(5):1227\u20131235. https:\/\/doi.org\/10.1242\/dmm.012765","journal-title":"Dis Model Mech"},{"issue":"12","key":"3160_CR348","doi-asserted-by":"publisher","first-page":"e113542","DOI":"10.1371\/journal.pone.0113542","volume":"9","author":"Q Li","year":"2014","unstructured":"Li Q et al (2014) Spontaneous asj-2J mutant mouse as a model for generalized arterial calcification of infancy: a large deletion\/insertion mutation in the Enpp1 gene. PLoS ONE 9(12):e113542. https:\/\/doi.org\/10.1371\/journal.pone.0113542","journal-title":"PLoS ONE"},{"issue":"5","key":"3160_CR349","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1002\/jbmr.4254","volume":"36","author":"CR Ferreira","year":"2021","unstructured":"Ferreira CR et al (2021) Response of the ENPP1-deficient skeletal phenotype to oral phosphate supplementation and\/or enzyme replacement therapy: Comparative studies in humans and mice. J Bone Min Res 36(5):942\u2013955. https:\/\/doi.org\/10.1002\/jbmr.4254","journal-title":"J Bone Min Res"},{"key":"3160_CR350","doi-asserted-by":"publisher","unstructured":"Shimada BK, Pomozi V, Zoll J, Kuo S, Martin L, Le Saux O (2021) ABCC6, Pyrophosphate and Ectopic Calcification: Therapeutic Solutions. Int J Mol Sci 22(9). https:\/\/doi.org\/10.3390\/ijms22094555","DOI":"10.3390\/ijms22094555"},{"issue":"2","key":"3160_CR351","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1111\/j.1468-3083.2005.01007.x","volume":"19","author":"B Fabre","year":"2005","unstructured":"Fabre B, Bayle P, Bazex J, Durand D, Lamant L, Chassaing N (2005) Pseudoxanthoma elasticum and nephrolithiasis. J Eur Acad Dermatol Venereol 19(2):212\u2013215. https:\/\/doi.org\/10.1111\/j.1468-3083.2005.01007.x","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"3160_CR352","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1016\/0002-9343(87)90960-0","volume":"83","author":"LE Mallette","year":"1987","unstructured":"Mallette LE, Mechanick JI (Dec 1987) Heritable syndrome of pseudoxanthoma elasticum with abnormal phosphorus and vitamin D metabolism. Am J Med 83(6):1157\u20131162. https:\/\/doi.org\/10.1016\/0002-9343(87)90960-0","journal-title":"Am J Med"},{"issue":"6","key":"3160_CR353","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1016\/j.kint.2015.12.055","volume":"89","author":"H Seeger","year":"2016","unstructured":"Seeger H, Mohebbi N (2016) Pseudoxanthoma elasticum and nephrocalcinosis. Kidney Int 89(6):1407. https:\/\/doi.org\/10.1016\/j.kint.2015.12.055","journal-title":"Kidney Int"},{"issue":"8","key":"3160_CR354","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/gim.2016.213","volume":"19","author":"A Legrand","year":"2017","unstructured":"Legrand A et al (2017) Mutation spectrum in the ABCC6 gene and genotype-phenotype correlations in a French cohort with pseudoxanthoma elasticum. Genet Med 19(8):909\u2013917. https:\/\/doi.org\/10.1038\/gim.2016.213","journal-title":"Genet Med"},{"key":"3160_CR355","doi-asserted-by":"publisher","unstructured":"Letavernier E, Bouderlique E, Zaworski J, Martin L, Daudon M (2019) Pseudoxanthoma elasticum, kidney stones and pyrophosphate: From a rare disease to urolithiasis and vascular calcifications. Int J Mol Sci 20(24). https:\/\/doi.org\/10.3390\/ijms20246353","DOI":"10.3390\/ijms20246353"},{"issue":"9","key":"3160_CR356","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1681\/ASN.2017101148","volume":"29","author":"E Letavernier","year":"2018","unstructured":"Letavernier E et al (2018) ABCC6 Deficiency Promotes Development of Randall Plaque. J Am Soc Nephrol 29(9):2337\u20132347. https:\/\/doi.org\/10.1681\/ASN.2017101148","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"3160_CR357","doi-asserted-by":"publisher","first-page":"91","DOI":"10.2174\/1573403X14666181031141226","volume":"15","author":"D Azpiazu","year":"2019","unstructured":"Azpiazu D, Gonzalo S, Villa-Bellosta R (2019) Tissue Non-Specific Alkaline Phosphatase and Vascular Calcification: A Potential Therapeutic Target. Curr Cardiol Rev 15(2):91\u201395. https:\/\/doi.org\/10.2174\/1573403X14666181031141226","journal-title":"Curr Cardiol Rev"},{"key":"3160_CR358","doi-asserted-by":"publisher","unstructured":"Savinov AY, Salehi M, Yadav MC, Radichev I, Millan JL, Savinova OV (2015) Transgenic overexpression of tissue-nonspecific alkaline phosphatase (TNAP) in vascular endothelium results in generalized arterial calcification. J Am Heart Assoc 4(12). https:\/\/doi.org\/10.1161\/JAHA.115.002499","DOI":"10.1161\/JAHA.115.002499"},{"issue":"8","key":"3160_CR359","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1161\/ATVBAHA.117.309182","volume":"37","author":"AD de Ter Braake","year":"2017","unstructured":"Ter Braake AD, Shanahan CM, de Baaij JHF (2017) Magnesium counteracts vascular calcification: Passive interference or active modulation? Arterioscler Thromb Vasc Biol 37(8):1431\u20131445. https:\/\/doi.org\/10.1161\/ATVBAHA.117.309182","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"3160_CR360","doi-asserted-by":"publisher","first-page":"i15","DOI":"10.1093\/ndtplus\/sfr164","volume":"5","author":"JH de Baaij","year":"2012","unstructured":"de Baaij JH, Hoenderop JG, Bindels RJ (2012) Regulation of magnesium balance: lessons learned from human genetic disease. Clin Kidney J 5:i15\u2013i24. https:\/\/doi.org\/10.1093\/ndtplus\/sfr164","journal-title":"Clin Kidney J"},{"issue":"6","key":"3160_CR361","doi-asserted-by":"publisher","first-page":"ziaf065","DOI":"10.1093\/jbmrpl\/ziaf065","volume":"9","author":"K O\u2019Brien","year":"2025","unstructured":"O\u2019Brien K et al (2025) Recombinant ectonucleotide pyrophosphatase\/phosphodiesterase 1 (ENPP1) decreases vascular calcification and prevents osteomalacia in a rat model of chronic kidney disease. JBMR Plus 9(6):ziaf065. https:\/\/doi.org\/10.1093\/jbmrpl\/ziaf065","journal-title":"JBMR Plus"},{"key":"3160_CR362","doi-asserted-by":"publisher","unstructured":"Sekaran S, Vimalraj S, Thangavelu L (2021) The physiological and pathological role of tissue nonspecific alkaline phosphatase beyond mineralization. Biomolecules 11(11). https:\/\/doi.org\/10.3390\/biom11111564","DOI":"10.3390\/biom11111564"},{"key":"3160_CR363","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/164_2022_633","volume":"283","author":"CA Wagner","year":"2024","unstructured":"Wagner CA (2024) Pharmacology of Mammalian Na(+)-Dependent Transporters of Inorganic Phosphate. Handb Exp Pharmacol 283:285\u2013317. https:\/\/doi.org\/10.1007\/164_2022_633","journal-title":"Handb Exp Pharmacol"},{"issue":"5","key":"3160_CR364","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1021\/acsmedchemlett.8b00013","volume":"9","author":"KJ Filipski","year":"2018","unstructured":"Filipski KJ et al (2018) Discovery of orally bioavailable selective inhibitors of the sodium-phosphate cotransporter NaPi2a (SLC34A1). ACS Med Chem Lett 9(5):440\u2013445. https:\/\/doi.org\/10.1021\/acsmedchemlett.8b00013","journal-title":"ACS Med Chem Lett"},{"issue":"12","key":"3160_CR365","doi-asserted-by":"publisher","first-page":"6510","DOI":"10.1172\/JCI135665","volume":"130","author":"V Clerin","year":"2020","unstructured":"Clerin V et al (2020) Selective pharmacological inhibition of the sodium-dependent phosphate cotransporter NPT2a promotes phosphate excretion. J Clin Invest 130(12):6510\u20136522. https:\/\/doi.org\/10.1172\/JCI135665","journal-title":"J Clin Invest"},{"issue":"2","key":"3160_CR366","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1001\/jamacardio.2020.4511","volume":"6","author":"DK McGuire","year":"2021","unstructured":"McGuire DK et al (2021) Association of SGLT2 inhibitors with cardiovascular and kidney outcomes in patients with type 2 diabetes: A meta-analysis. JAMA Cardiol 6(2):148\u2013158. https:\/\/doi.org\/10.1001\/jamacardio.2020.4511","journal-title":"JAMA Cardiol"},{"issue":"8","key":"3160_CR367","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/s41581-024-00836-y","volume":"20","author":"DV O\u2019Hara","year":"2024","unstructured":"O\u2019Hara DV et al (2024) Applications of SGLT2 inhibitors beyond glycaemic control. Nat Rev Nephrol 20(8):513\u2013529. https:\/\/doi.org\/10.1038\/s41581-024-00836-y","journal-title":"Nat Rev Nephrol"},{"issue":"4","key":"3160_CR368","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1056\/NEJMoa1515920","volume":"375","author":"C Wanner","year":"2016","unstructured":"Wanner C et al (2016) Empagliflozin and progression of kidney disease in type 2 diabetes. N Engl J Med 375(4):323\u2013334. https:\/\/doi.org\/10.1056\/NEJMoa1515920","journal-title":"N Engl J Med"},{"key":"3160_CR369","doi-asserted-by":"publisher","unstructured":"G. Nuffield Department of Population Health Renal Studies and, i. M.-A. S, C.-R. T, Consortium Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials, Lancet, vol. 400, no. 10365, pp. 1788\u20131801, Nov 19 2022. https:\/\/doi.org\/10.1016\/S0140-6736(22)02074-8","DOI":"10.1016\/S0140-6736(22)02074-8"},{"issue":"24","key":"3160_CR370","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","volume":"380","author":"V Perkovic","year":"2019","unstructured":"Perkovic V et al (2019) Canagliflozin and renal outcomes in type 2 diabetes and nephropathy. N Engl J Med 380(24):2295\u20132306. https:\/\/doi.org\/10.1056\/NEJMoa1811744","journal-title":"N Engl J Med"},{"issue":"15","key":"3160_CR371","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","volume":"383","author":"HJL Heerspink","year":"2020","unstructured":"Heerspink HJL et al (2020) Dapagliflozin in patients with chronic kidney disease. N Engl J Med 383(15):1436\u20131446. https:\/\/doi.org\/10.1056\/NEJMoa2024816","journal-title":"N Engl J Med"},{"issue":"2","key":"3160_CR372","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1056\/NEJMoa2204233","volume":"388","author":"E-KCG The","year":"2023","unstructured":"The E-KCG et al (2023) Empagliflozin in patients with chronic kidney disease. N Engl J Med 388(2):117\u2013127. https:\/\/doi.org\/10.1056\/NEJMoa2204233","journal-title":"N Engl J Med"},{"issue":"4","key":"3160_CR373","doi-asserted-by":"publisher","first-page":"650","DOI":"10.2337\/dc08-1863","volume":"32","author":"JF List","year":"2009","unstructured":"List JF, Woo V, Morales E, Tang W, Fiedorek FT (2009) Sodium-glucose cotransport inhibition with dapagliflozin in type 2 diabetes. Diabetes Care 32(4):650\u2013657. https:\/\/doi.org\/10.2337\/dc08-1863","journal-title":"Diabetes Care"},{"issue":"1","key":"3160_CR374","doi-asserted-by":"publisher","first-page":"66","DOI":"10.2215\/CJN.04530418","volume":"14","author":"MA de Jong","year":"2019","unstructured":"de Jong MA et al (2019) Effects of dapagliflozin on circulating markers of phosphate homeostasis. Clin J Am Soc Nephrol 14(1):66\u201373. https:\/\/doi.org\/10.2215\/CJN.04530418","journal-title":"Clin J Am Soc Nephrol"},{"key":"3160_CR375","doi-asserted-by":"publisher","unstructured":"Wagner CA (2025) Beyond SGLT2: proximal tubule transporters as potential drug targets for chronic kidney disease. Nephrol Dial Transpl 40 no. Supplement_1, pp. i18\u2013i28, Feb 5. https:\/\/doi.org\/10.1093\/ndt\/gfae211","DOI":"10.1093\/ndt\/gfae211"},{"issue":"1","key":"3160_CR376","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/S2213-8587(14)70227-X","volume":"3","author":"SI Taylor","year":"2015","unstructured":"Taylor SI, Blau JE, Rother KI (Jan 2015) Possible adverse effects of SGLT2 inhibitors on bone. Lancet Diabetes Endocrinol 3(1):8\u201310. https:\/\/doi.org\/10.1016\/S2213-8587(14)70227-X","journal-title":"Lancet Diabetes Endocrinol"},{"key":"3160_CR377","doi-asserted-by":"publisher","unstructured":"Blau JE et al (2018) Canagliflozin triggers the FGF23\/1,25-dihydroxyvitamin D\/PTH axis in healthy volunteers in a randomized crossover study. JCI Insight 3(8). https:\/\/doi.org\/10.1172\/jci.insight.99123","DOI":"10.1172\/jci.insight.99123"},{"key":"3160_CR378","doi-asserted-by":"publisher","first-page":"111818","DOI":"10.1016\/j.diabres.2024.111818","volume":"216","author":"GCK Chan","year":"2024","unstructured":"Chan GCK, Ng JKC, Szeto CC, Chow KM (2024) Effects on calcium phosphate homeostasis after sodium-glucose cotransporter 2 inhibitor in patients with advanced chronic kidney disease and type 2 diabetes mellitus. Diabetes Res Clin Pract 216:111818. https:\/\/doi.org\/10.1016\/j.diabres.2024.111818","journal-title":"Diabetes Res Clin Pract"},{"issue":"7","key":"3160_CR379","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1007\/s00125-021-05424-4","volume":"64","author":"KB Kristensen","year":"2021","unstructured":"Kristensen KB, Henriksen DP, Hallas J, Pottegard A, Lund LC (2021) Sodium-glucose cotransporter 2 inhibitors and risk of nephrolithiasis. Diabetologia 64(7):1563\u20131571. https:\/\/doi.org\/10.1007\/s00125-021-05424-4","journal-title":"Diabetologia"},{"key":"3160_CR380","doi-asserted-by":"publisher","first-page":"106524","DOI":"10.1016\/j.phrs.2022.106524","volume":"186","author":"G Anan","year":"2022","unstructured":"Anan G et al (2022) Inhibition of sodium-glucose cotransporter 2 suppresses renal stone formation. Pharmacol Res 186:106524. https:\/\/doi.org\/10.1016\/j.phrs.2022.106524","journal-title":"Pharmacol Res"},{"issue":"3","key":"3160_CR381","doi-asserted-by":"publisher","first-page":"e059073","DOI":"10.1136\/bmjopen-2021-059073","volume":"12","author":"S Schietzel","year":"2022","unstructured":"Schietzel S et al (2022) Impact of the SGLT2 inhibitor empagliflozin on urinary supersaturations in kidney stone formers (SWEETSTONE trial): protocol for a randomised, double-blind, placebo-controlled cross-over trial. BMJ Open 12(3):e059073. https:\/\/doi.org\/10.1136\/bmjopen-2021-059073","journal-title":"BMJ Open"},{"issue":"7","key":"3160_CR382","doi-asserted-by":"publisher","first-page":"e3003","DOI":"10.1210\/clinem\/dgac154","volume":"107","author":"P Balasubramanian","year":"2022","unstructured":"Balasubramanian P et al (2022) Empagliflozin and decreased risk of nephrolithiasis: A potential new role for SGLT2 inhibition? J Clin Endocrinol Metab 107(7):e3003\u2013e3007. https:\/\/doi.org\/10.1210\/clinem\/dgac154","journal-title":"J Clin Endocrinol Metab"},{"key":"3160_CR383","doi-asserted-by":"publisher","first-page":"174715","DOI":"10.1016\/j.ejphar.2021.174715","volume":"918","author":"E Abdollahi","year":"2022","unstructured":"Abdollahi E, Keyhanfar F, Delbandi AA, Falak R, Hajimiresmaiel SJ, Shafiei M (2022) Dapagliflozin exerts anti-inflammatory effects via inhibition of LPS-induced TLR-4 overexpression and NF-kappaB activation in human endothelial cells and differentiated macrophages. Eur J Pharmacol 918:174715. https:\/\/doi.org\/10.1016\/j.ejphar.2021.174715","journal-title":"Eur J Pharmacol"},{"issue":"6","key":"3160_CR384","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1093\/ndt\/gfac026","volume":"37","author":"NHJ Leenders","year":"2022","unstructured":"Leenders NHJ, Bos C, Hoekstra T, Schurgers LJ, Vervloet MG, Hoenderop JGJ (2022) Dietary magnesium supplementation inhibits abdominal vascular calcification in an experimental animal model of chronic kidney disease. Nephrol Dial Transpl 37(6):1049\u20131058. https:\/\/doi.org\/10.1093\/ndt\/gfac026","journal-title":"Nephrol Dial Transpl"},{"issue":"5","key":"3160_CR385","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1016\/j.kint.2017.04.011","volume":"92","author":"JM Diaz-Tocados","year":"2017","unstructured":"Diaz-Tocados JM et al (2017) Dietary magnesium supplementation prevents and reverses vascular and soft tissue calcifications in uremic rats. Kidney Int 92(5):1084\u20131099. https:\/\/doi.org\/10.1016\/j.kint.2017.04.011","journal-title":"Kidney Int"},{"key":"3160_CR386","doi-asserted-by":"publisher","unstructured":"Zaslow SJ, Oliveira-Paula GH, Chen W (2024) Magnesium and vascular calcification in chronic kidney disease: current insights. Int J Mol Sci 25(2). https:\/\/doi.org\/10.3390\/ijms25021155","DOI":"10.3390\/ijms25021155"},{"issue":"9","key":"3160_CR387","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.2215\/CJN.13921217","volume":"13","author":"I Bressendorff","year":"2018","unstructured":"Bressendorff I, Hansen D, Schou M, Pasch A, Brandi L (2018) The effect of increasing dialysate magnesium on serum calcification propensity in subjects with end stage kidney disease: A randomized, controlled clinical trial. Clin J Am Soc Nephrol 13(9):1373\u20131380. https:\/\/doi.org\/10.2215\/CJN.13921217","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"3160_CR388","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1093\/ndt\/gfz234","volume":"36","author":"I Bressendorff","year":"2021","unstructured":"Bressendorff I et al (2021) The effect of increasing dialysate magnesium on calciprotein particles, inflammation and bone markers: post hoc analysis from a randomized controlled clinical trial. Nephrol Dial Transpl 36(4):713\u2013721. https:\/\/doi.org\/10.1093\/ndt\/gfz234","journal-title":"Nephrol Dial Transpl"},{"key":"3160_CR389","doi-asserted-by":"publisher","unstructured":"Schmaderer C et al (2017) Reduced mortality in maintenance haemodialysis patients on high versus low dialysate magnesium: A pilot study. Nutrients 9(9) https:\/\/doi.org\/10.3390\/nu9090926","DOI":"10.3390\/nu9090926"},{"issue":"5","key":"3160_CR390","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/ki.2010.461","volume":"79","author":"WC O\u2019Neill","year":"2011","unstructured":"O\u2019Neill WC, Lomashvili KA, Malluche HH, Faugere MC, Riser BL (2011) Treatment with pyrophosphate inhibits uremic vascular calcification. Kidney Int 79(5):512\u2013517. https:\/\/doi.org\/10.1038\/ki.2010.461","journal-title":"Kidney Int"},{"issue":"10","key":"3160_CR391","doi-asserted-by":"publisher","first-page":"3349","DOI":"10.1093\/ndt\/gfr039","volume":"26","author":"BL Riser","year":"2011","unstructured":"Riser BL et al (2011) Daily peritoneal administration of sodium pyrophosphate in a dialysis solution prevents the development of vascular calcification in a mouse model of uraemia. Nephrol Dial Transpl 26(10):3349\u20133357. https:\/\/doi.org\/10.1093\/ndt\/gfr039","journal-title":"Nephrol Dial Transpl"},{"issue":"5","key":"3160_CR392","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/ki.2010.478","volume":"79","author":"VP Persy","year":"2011","unstructured":"Persy VP, McKee MD (2011) Prevention of vascular calcification: is pyrophosphate therapy a solution? Kidney Int 79(5):490\u2013493. https:\/\/doi.org\/10.1038\/ki.2010.478","journal-title":"Kidney Int"}],"container-title":["Pfl\u00fcgers Archiv - European Journal of Physiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00424-026-03160-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00424-026-03160-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00424-026-03160-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:06:41Z","timestamp":1781644001000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00424-026-03160-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,30]]},"references-count":392,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["3160"],"URL":"https:\/\/doi.org\/10.1007\/s00424-026-03160-5","relation":{},"ISSN":["0031-6768","1432-2013"],"issn-type":[{"value":"0031-6768","type":"print"},{"value":"1432-2013","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,30]]},"assertion":[{"value":"24 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"C.F. has served as consultant for Bayer and Calico Labs. C.F. is an inventor on two pending patents (PCT\/US2019\/049211; PCT\/US19\/49161), and he has a patent on FGFR inhibition (European Patent No. 2723391). C.F. is the co-founder and CSO of a startup biotech company (Alpha Young LLC). C.F. received honoraria for publishing a book (\u201cFGF23\u201d, Elsevier, ISBN9780128180365). T.M., V.V. and A.F. declare that there is no competing interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"34"}}